Amphetamine, Methamphetamine and Their Ring-Substituted Analogues in Seized Materials

Vienna International Centre, P.O.
Box 500, 1400 Vienna, Austria

Tel: (+43-1) 26060-0, Fax: (+43-1) 26060-5866, www.unodc.org
RECOMMENDED METHODS FOR

THE IDENTIFICATION AND ANALYSIS OF
AMPHETAMINE, METHAMPHETAMINE
AND THEIR RING-SUBSTITUTED
ANALOGUES IN SEIZED MATERIALS
(revised and updated)
MANUAL FOR USE BY NATIONAL DRUG TESTING LABORATORIES

Laboratory and Scientific Section
United Nations Office on Drugs and Crime
Vienna
RECOMMENDED METHODS FOR THE

IDENTIFICATION AND ANALYSIS OF
ANALOGUES
IN SEIZED MATERIALS
UNITED NATIONS
New York, 2006
Note
Mention of company names and commercial products does not imply the endorse-
ment of the United Nations. This publication has not been formally edited.
ST/NAR/34
UNITED NATIONS PUBLICATION

Sales No. E.06.XI.1
ISBN 92-1-148208-9
Acknowledgements
UNODC’s Laboratory and Scientific Section wishes to express its thanks to the
experts who participated in the Consultative Meeting on “The Review of Methods
for the Identification and Analysis of Amphetamine-type Stimulants (ATS) and
Their Ring-substituted Analogues in Seized Material” for their contribution to the
contents of this manual.
Ms. Rosa Alis Rodríguez, Laboratorio de Drogas y Sanidad de Baleares,

Palma de Mallorca, Spain
Dr. Hans Bergkvist, SKL—National Laboratory of Forensic Science,

Linköping, Sweden
Ms. Warank Boonchuay, Division of Narcotics Analysis, Department of

Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand
Dr. Rainer Dahlenburg, Bundeskriminalamt/KT34, Wiesbaden, Germany
Mr. Adrian V. Kemmenoe, The Forensic Science Service, Birmingham

Laboratory, Birmingham, United Kingdom
Dr. Tohru Kishi, National Research Institute of Police Science, Chiba, Japan
Dr. Waldemar Krawczyk, Central Forensic Laboratory of the Police, Ministry

of Interior and Administration, Warsaw, Poland
Mr. Ira Lurie, Special Testing and Research Laboratory, Drug Enforcement
Administration, Dulles, Virginia, United States of America
Dr. Yukiko Makino, Narcotics Control Department, Kanto-Shin’etsu Bureau

of Health and Welfare, Ministry of Health, Labour and Welfare, Tokyo, Japan
Mr. Tim McKibben, Special Testing and Research Laboratory, Drug

Enforcement Administration, Dulles, Virginia, United States of America
Ms. Anneke Poortman, Forensic Science Laboratory, Ministry of Justice,

Rijswijk, the Netherlands
Ms. Jana Skopec*, Australian Government Analytical Laboratories, Pymble,

NSW, Australia
*Now with Agrifor Scientific Pty Ltd., Australia.
iii
Mr. Takahiro Terasaki, Kanto-Shin’etsu Regional Narcotics Control Office,
Ministry of Health and Welfare, Tokio, Japan
UNODC’s Laboratory and Scientific Section also wishes to express its thanks
to Ms. Jana Skopec for reviewing, updating and finalizing the manuscript, also
with additional contributions from the meeting participants.*
*The review of the draft manual by Dr. Ken Tanaka, National Police Agency, Japan, is also
greatly acknowledged.
iv
Contents
Page
I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
II. Use of the manual . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
III. Classification/definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
IV. Description of pure compounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

A. Stereochemistry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
B. Physical characteristics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
V. Illicit ATS manufacture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
A. Amphetamine synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
B. Methamphetamine synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
C. Synthesis of ring-substituted ATS . . . . . . . . . . . . . . . . . . . . . . . . 14
VI. Qualitative and quantitative analysis of ATS . . . . . . . . . . . . . . . . 17
A. Presumptive tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1. Colour tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2. Anion tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
3. Microcrystal tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
B. Thin layer chromatography (TLC) . . . . . . . . . . . . . . . . . . . . . . . 24
C. Gas chromatography (GC)—flame ionization detector (FID) . . 30
1. Qualitative analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2. Quantitative analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
D. Gas chromatography-mass spectrometry (GC-MS) . . . . . . . . . . 36
E. High performance liquid chromatography (HPLC) . . . . . . . . . . 38
F. Fourier transform infrared (FTIR) spectroscopy . . . . . . . . . . . . 40
G. Analysis of optical isomers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
1. Melting point . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2. Microcrystal tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3. Instrumental techniques . . . . . . . . . . . . . . . . . . . . . . . . . . 46
VII. Additional analytical techniques for the analysis of ATS . . . . . . 51
A. 1H-Nuclear magnetic resonance (NMR) techniques . . . . . . . . . . 51
B. Capillary electrophoresis (CE) . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
C. Solid phase-micro extraction-gas chromatography (SPME-GC) 53
D. Gas chromatography-fourier transform infrared spectroscopy
(GC-FTIR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Annexes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
v
I. INTRODUCTION
International attention is focusing more and more on the growing issue of

amphetamine-type stimulants (ATS). Particularly over the last 10 to 15 years,
abuse of ATS, involving amphetamines (amphetamine and methamphetamine) and
substances of the “ecstasy”-group (MDMA, MDA, MDEA, etc.), has become a
global problem. There are regional differences, but today no country is spared one
of the many facets of ATS manufacture, trafficking or abuse.
This new situation, involving often new and unfamiliar ATS, or combina-
tions, and trafficking trends, presents a challenge both to national law enforce-
ment authorities and to the scientific staff of forensic laboratories.
Today, analysts must be able to analyse a wide range of substances and prepa-
rations, and use faster, more accurate and more specific methods for identifica-
tion and analysis in order to cope with the increased analysis turnover and the
requirements of stiffer national drug laws. In addition, the international character
of drug trafficking requires the timely exchange of analytical data between labo-
ratories and law enforcement authorities at the national, regional and internatio-
nal levels. For these reasons, UNODC’s Laboratory and Scientific Section has
since the early 1980s pursued a programme of harmonization and establishment
of recommended methods of testing for national drug testing laboratories.
A consultative meeting comprised of 13 experts was convened in September
1998 in London by UNODC’s Laboratory and Scientific Section in cooperation
with the Forensic Science Service of the United Kingdom to review methods for
the identification and analysis of amphetamine-type stimulants (ATS) and their
ring-substituted analogues in seized material. This manual reflects the conclusions
of that meeting, reviewed and up-dated again in 2004/05. It provides practical
assistance to national authorities by describing recommended methods to be used
in drug testing laboratories for the identification and analysis of amphetamine-
type stimulants (ATS) and their ring-substituted analogues.
This manual is one in a series of similar publications dealing with the iden-
tification and analysis of various groups of drugs under international control. It
combines and replaces previously published manuals on Recommended Methods
for Testing Amphetamine and Methamphetamine (ST/NAR/9, 1987) and
Recommended Methods for Testing Illicit Ring-Substituted Amphetamine
Derivatives (ST/NAR/12, 1988).
The present and previous manuals suggest approaches that may assist drug
analysts in the selection of methods appropriate to the sample under examination,
leaving room also for adaptation to the level of sophistication of different labo-
ratories. For the first time in this series of publications, the present manual has
1
2 Methods for the identification and analysis of amphetamine, methamphetamine
also annexed selected validated methods. Most methods described are published
in the scientific literature, and have been used for a number of years in reputable
laboratories. In identifying those methods, the consultative meeting was aware that
a number of other published methods in the forensic science literature also pro-
duce acceptable results.
The present manual is limited to analytical methods for ATS. A separate
manual on analytical techniques more generally, and their characteristics and prac-
tical use for drug analysis, complements this series of manuals on recommended
methods.
II. USE OF THE MANUAL
Not all methods described in this manual need to be applied to all samples sus-
pected to consist of or contain amphetamine, methamphetamine or other ATS.
The choice of the methodology and approach to their analysis remains within the
discretion of the analyst and depends on the type of drug involved, the availabil-
ity of appropriate instrumentation and of reference materials as well as on the
level of legally acceptable proof in the jurisdiction within which the analyst works.
While it is therefore recognized that unique requirements in different jurisdic-
tions may dictate the actual practices followed by a particular laboratory, good
laboratory practice (GLP) requires that an analytical approach to establish the iden-
tity of a controlled drug in suspected material must, as a minimum, entail the deter-
mination of at least two uncorrelated parameters. The selection of these parameters
in any particular case would have to take into account the drug involved and the
laboratory resources available to the analyst. When possible, three entirely differ-
ent analytical techniques should be used, for example: colour tests, chromatogra-
phy (e.g., TLC, GC or HPLC) and spectroscopy (e.g., IR or UV). Hyphenated
techniques, such as GC-MS, count as two parameters, provided the information
from both techniques is used (i.e. retention time and mass spectral characteristics).
Attention is also drawn to the vital importance of the availability to drug
analysts of reference books on drugs of abuse and analytical techniques. Moreover,
the analyst must of necessity keep abreast of current trends in drug analysis, con-
sistently following current analytical and forensic science literature. UNODC
assists laboratories in this regard by providing, upon request, selected articles from
the scientific literature.
UNODC’s Laboratory and Scientific Section would welcome observations on
the contents and usefulness of the present manual. Comments and suggestions
may be addressed to:
Laboratory and Scientific Section
United Nations Office on Drugs and Crime
Vienna International Centre
P.O. Box 500
1400 Vienna, Austria
Fax: (+43-1) 26060-5967
E-mail: lab@unodc.org
All manuals, as well as guidelines and other scientific-technical publications may

be requested by contacting the address above.
3
III. CLASSIFICATION/DEFINITIONS
Amphetamine-type stimulants (ATS) are a group of substances, mostly synthetic

in origin, that are structurally derived from 웁-phenethylamine (웁-PEA, figure I).
ATS generally stimulate the central nervous system (CNS). Therefore, to varying
degrees, they are considered as prototypes of central nervous system stimulants
웁
with a potential of psychotic toxicity when overdosed or
NH2 abused for long periods of time. ATS may produce one
움 or more dose-related symptoms, including increased
alertness and euphoria, increased heart rate, blood pres-
Figure I
sure, respiration and body temperature. Agitation,
tremors, hypertension, memory loss, hallucinations,
psychotic episodes, paranoid delusions, and violent behaviour can result from
chronic abuse. Withdrawal from high doses of ATS could result in severe depres-
sion. ATS are illegally produced in a variety of preparations (powder, tablets, or
capsules), and they may be injected, ingested orally, snorted, or smoked.
Chemical modification at the positions
R1 to R9* (figure II) results in a practically R9 R4 R1
unlimited number of pharmacologically active R8 N
compounds, some of which are more potent R2
stimulants than others. Although there are sev-
R3
eral possibilities for side chain modification, R7 R5
substitution on the aromatic ring contributes
the most to substantial qualitative differences R6
in pharmacological effects. Figure II
In terms of structural characteristics, ATS
can be divided into three major sub-groups, which largely correspond to the fol-
lowing substitution patterns on the aromatic ring:
(a) No substitution on aromatic ring (e.g. amphetamine, methamphetamine,
fenetylline).
(b) Methylenedioxy-substitution on aromatic ring (e.g. MDA, MDMA,
MBDB).
(c) Other substitution patterns, usually including one or more alkyloxy
group (e.g. 2C-B, STP/DOM).
*All other substituents required to saturate valences are not shown, as they are usually
hydrogen (H).
5
For practical reasons, this manual provides specific data only for a selection
of the most common ATS. In particular, it includes ATS under international con-
trol and selected ATS under national control. The analyst should be aware that
other closely related analogues may be encountered. In most cases, the method-
ology presented will be applicable to those analogues as well.
The chemical structures of selected ATS, together with common names and
IUPAC nomenclature, are given in annex I.
IV. DESCRIPTION OF PURE COMPOUNDS
Seized ATS are commonly encountered in the form of salts, in particular as

hydrochloride, sulphate, phosphate, or bromide salt. However, it is not uncom-
mon in clandestine laboratory investigations to find those compounds in base form
as well (usually a brownish oily liquid). Salts are crystalline or powdered sub-
stances, which vary in colour from white (similar to pharmaceutical grade prod-
ucts) to pink, yellow or brown. They are often damp with a characteristic smell,
owing to the presence of solvent and/or precursor residues.
ATS can be also found in the form of tablets. In addition to the active ATS,
tablets often contain different adulterants, cutting agents, common food colours
and/or different excipients and binding agents.
Amphetamine: Illicit amphetamine is frequently encountered as the sulphate
salt in powder form, and rarely as tablet. Amphetamine base may be seized in
clandestine laboratories, typically as a dark brown oily liquid with a characteris-
tic unpleasant smell of 1-phenyl-2-propanone (P-2-P) and/or solvent residues.
Methamphetamine: Illicitly manufactured methamphetamine is available in dif-
ferent forms, depending on the geographical region. Forms include powder, crystals
(commonly known as “Cristal”, “Ice” or “Shabu”) and tablets (commonly known as
“Yaba”). The most frequently encountered salt form is the hydrochloride.
Methylenedioxy ring-substituted ATS: MDMA, MDA, and MDEA are usually
found as tablets which may or may not bear one of a logo. Powders are only
occasionally found, but typically contain high concentration of active substances.
Tablets are frequently brightly coloured; they often vary in size. The drug con-
tent usually ranges from 40-140 mg. Regional differences in drug content, and
changes over time, are known. In Europe, for example, the average MDMA con-
tent in ecstasy tablets has dropped to about 60-70 mg (compared to around 100 mg
in the mid-1990s).
The most commonly encountered salt form of the methylenedioxy-type ATS
is the hydrochloride, but phosphate and bromide salts are also seen.
A. STEREOCHEMISTRY
Most ATS have at least one chiral centre and can therefore be found as a racemic
mixture or as individual enantiomers.* In illicit markets, most ATS are encountered
*The terms (d) or (+), (l) or (-) and (d,l) or (±) are typically used to designate the optical rota-
tion of chiral substances. (R) and (S) designations describe the absolute steric configuration of sub-
stituents at individual chiral centres, and are preferred, especially in the case of diastereomers.
7
in a typical stereochemical make-up. Amphetamine, for example, and most ring-

substituted ATS, are typically encountered as the racemate, while methampheta-
mine is frequently seen as S-, or dextro, enantiomer (also known as “Ice”, or
“Shabu”), in addition to the racemate. The analysis of optical isomers is described
in chapter VI.G. below.
B. PHYSICAL CHARACTERISTICS
Melting/boiling points: The melting and/or boiling points are available for
the most commonly encountered ATS. The analyst should be aware, however, that
such data refer to pure substances.* Except for high purity ATS, such as crys-
talline methamphetamine (“Ice”), melting points should therefore only be used as
a presumptive test (for the use of melting points for the differentiation of isomers,
see chapter VI.G.1, below).
Solubilities: The solubilities of selected ATS and their salts are provided in
the section on anion tests (see p. 21 below). Selective re-crystallization based on
differences in solubilities can be used for the separation of some ATS salts (see
Chapter VI.F. on FTIR, below).
Spectroscopic data: Mass spectral (MS), infra red (IR) and nuclear magnetic
resonance (NMR) data of the most common ATS are available in the earlier
edition of the two UN manuals related to the analysis of ATS, namely,
“Recommended methods for testing amphetamine and methamphetamine”
(ST/NAR/9), and “Recommended methods for testing illicit ring-substituted
amphetamine derivatives” (ST/NAR/12). Data can also be accessed at the
Laboratory and Scientific Section’s web page.
*The analyst should also be aware that melting points for some ATS may also vary depending
on the solvent used for crystallization.
V. ILLICIT ATS MANUFACTURE
Knowledge of illicit manufacturing routes of drugs of abuse can play an impor-

tant role in the interpretation of analytical results, especially in those cases where
more in-depth analyses of impurities and manufacturing by-products, so-called
impurity profiling studies, are carried out.
Use of illicitly obtained or published methods (“underground literature” or
internet) for synthesis, inexperienced clandestine “chemists”, inappropriate labo-
ratory equipment and lack of laboratory quality control often result in impure and
inferior products, and variability in quality and potency. As a consequence, illic-
itly manufactured drugs often contain by-products and intermediates stemming
from impure starting materials, incomplete reactions, and inadequate purification
of intermediates and the final synthetic product. The types and quantities of impu-
rities present in illicit ATS samples (the “impurity profile”) largely depend on the
method of synthesis, the proportions, source and purity of starting materials, the
reaction conditions, and the purification procedures, if any.
The presence or absence of specific impurities (markers) can be useful in
determining the synthetic route employed, and the starting materials (precursors)
used. Solvent analysis can further add to the body of information, and thus can
be a useful tool for ATS sample comparison and characterization.
While impurity profiling studies are not the subject of this manual, some of
the methods described can be adapted for such purposes.*
Several synthesis routes for ATS are described in the literature and used by
illegal/clandestine manufacturers. Most commonly used synthetic methods for the
illicit manufacture of amphetamine can be also altered to produce methampheta-
mine or ring-substituted amphetamines. This is most often accomplished by sub-
stituting the amine source or the source of the aromatic ring, respectively, during
the reaction process. In general, the availability of precursors greatly determines
the choice of synthesis route used in illicit operations.
Brief descriptions of the most commonly employed synthetic routes for
amphetamine, methamphetamine and MDMA are presented below.**
Synthesis routes are classified on the basis of the reduction species used in
the reaction and the reduction mechanism. In practice, many of those reactions
*For a general introduction to the subject, the reader is referred to the United Nations manual
“Drug characterization/impurity profiling: Background and concepts” (ST/NAR/32/Rev.1, 2001); for
more specific methods and approaches for the impurity profiling of methamphetamine see also UNODC
Scientific and Technical Publication No.17 (SCITEC/17), 2000.
**For additional details, the reader is referred to the United Nations manual “Clandestine manu-
facture of substances under international control” (ST/NAR/10/Rev.2, 1998)
9
are known by popular names such as “Leuckart” method, hydriodic acid/red phos-
phorus, oxime, nitrostyrene, Birch or “Emde” method. Those popular names are
based on the chemist who first described the method, or on characteristic reagents
or important intermediates. Popular names are included whenever possible.
A. AMPHETAMINE SYNTHESIS
The central reaction of all methods used for the synthesis of amphetamine is based on
the catalytic reduction of 1-phenyl-2-propanone (P-2-P, benzyl methyl ketone, BMK,
phenylacetone) in the presence of ammonia or methylamine. The most popular reduc-
tion methods today are the Leuckart method (non-metal reduction) and the catalytic
metal reduction (reductive amination, catalytic hydrogenation or hydrogenolysis).
Leuckart reaction (non-metal reduction)
Due to its simplicity, the “Leuckart” reaction continues to be one of the most
popular synthetic routes employed for the illicit manufacture of amphetamines.
The Leuckart synthesis is a non-metal reduction usually carried out in three steps.
For amphetamine synthesis, a mixture of P-2-P and formamide (sometimes
in the presence of formic acid), or ammonium formate, is heated until a conden-
sation reaction results in the intermediate product N-formylamphetamine. In the
second step, N-formylamphetamine is hydrolysed typically using hydrochloric acid
(see figure III). The reaction mixture is then basified, isolated, and (steam) dis-
tilled. In the final step, the product is precipitated out of the solution, typically
as the sulphate salt. Amphetamine base is an oily liquid with a characteristic
“fishy-amine” odour.
Figure III. Leuckart reaction used in illicit amphetamine manufacture
HN O HCOOH
+ 2
O HN
O
P-2-P formamide N-formylamphetamine
HCl
HN NH2
O
N-formylamphetamine amphetamine
Illicit ATS manufacture 11
The Leuckart method is one of the most studied methods. Several route-
specific impurities were identified and described in the literature. The most promi-
nent impurities are the intermediate N-formylamphetamine (usually carried over
into the final product) and 4-methyl-5-phenyl pyrimidine. Other synthetic routes
do not give as many route-specific impurities as the Leuckart method.
Reductive amination (catalytic metal reduction)
Reductive amination is a process of catalytic or chemical reduction of aldehydes

and ketones in the presence of ammonia, or a primary or secondary amine, result-
ing in the related amine of higher order. The reaction mechanism proceeds through
the formation of an imine or iminium intermediate upon reaction of a carbonyl
compound with an appropriate amino compound, followed by reduction. Synthesis
of amphetamine using reductive amination methods utilizes P-2-P and a catalyst
of choice. The most frequently used methods can be divided into three different
types based on the reducing species:
(a) Heterogeneous catalytic reduction using platinum oxide, palladium or

Raney nickel
(b) Dissolving metal reduction using aluminum, zinc or magnesium amalgams
(c) Metal hydride reduction using lithium aluminum hydride (LiAlH4),
sodium borohydride (NaBH4) or, less frequently, sodium cyanoboro-
hydride (NaCNBH3).
Heterogeneous catalytic reduction is usually achieved by using a mixture of

P-2-P and ammonia gas charged with hydrogen in the presence of a selected cata-
lyst. Palladium on charcoal (Pd/C) or platinum oxide are the most commonly used
catalysts, followed by Raney nickel. Reductions are typically achieved at low pres-
sure and low temperature. In rare occasions, high-pressure aminations in a Parr pres-
sure reaction apparatus (“pressure” or “pipe bomb”) have also been encountered.
Dissolving metal reduction using aluminum, zinc or magnesium amalgams is
the one of most commonly used reductive amination method. The most popular
procedure uses aluminum-mercury amalgam (Al-Hg). The mechanism of the amal-
gam reduction proceeds via the reduction of a Schiff base adduct of P-2-P and
the appropriate amine. In crude clandestine conditions, this method utilizes
aluminum foil or grit, and mercuric chloride (HgCl2).
The most characteristic impurities from reductive aminations are Schiff bases,
postulated as being formed by the condensation of P-2-P and amphetamine, how-
ever they are not route-specific impurities and may be present in any synthetic
procedure involving P-2-P. P-2-P and imine type compounds may be also found
as impurities. Inorganic impurities arising from the use of a particular catalyst
may serve as markers.
Other, less frequently used reductive amination methods include metal

hydride reductions, such as the “nitropropane” route and the “oxime” route, named
after characteristic intermediates (phenyl-nitropropene and oxime, respectively),
which are formed during the reaction.
The oxime route is a reaction of P-2-P with hydroxylamine. The oxime inter-
mediate is subsequently hydrogenated to yield amphetamine. An oxime interme-
diate is usually hydrolysed by metal reduction using Pd/H2, or by metal hydride
reduction using LiAlH4.
The nitropropene route involves the condensation of benzaldehyde with
nitroethane, which yields 1-phenyl-2-nitropropene. Subsequent hydrogenation of
the double bond and reduction of the nitro-group results in amphetamine. The
reduction phase is usually completed using Pd/H2 or LiAlH4.
B. METHAMPHETAMINE SYNTHESIS
Methamphetamine can be also synthesized using the above methods by replacing

ammonia with methylamine.
However, the most popular methamphetamine synthetic routes employ
ephedrine or pseudoephedrine as a precursor instead of P-2-P. The reactions are
usually done by one of the following reactions (see figure IV):
(a) non-metal reductions such as the “hydriodic acid-red phosphorus”

method,
(b) dissolving metal reduction such as the “Birch” reduction, or
(c) heterogeneous catalytic reduction using thionylchloride and palladium or
platinum oxide as a catalyst (“Emde” method).
Figure IV. Common routes for illicit methamphetamine manufacture

Hydriodic acid-red phosphorous route (Nagai route)
OH
NH NH
HI
P (red)
ephedrine or methamphetamine
pseudoephedrine
Dissolving metal reduction (Birch reduction)

OH
NH NH3 NH
Li or Na metal
ephedrine or methamphetamine
pseudoephedrine
Figure IV. (continued)
Heterogeneous catalytic reduction (Emde route)
OH Cl
NH NH
NH SOCl2, or Pd/H2
POCl3
ephedrine or chloroephedrine methamphetamine

pseudoephedrine
Other reactions, such as the “nitropropene” or “oxime” route, are rarely

encountered.
Ephedrine and pseudoephedrine are widely available in pharmaceutical cough
preparations, many of which are available over-the-counter. The Chinese herb
Ma-huang, which is encountered in a number of food supplement and lifestyle
products is another source of those precursors.
Unlike P-2-P, ephedrine and pseudoephedrine are chiral substances. They are
diastereomers, and exist in two enantiomeric forms, each (d- and l-ephedrine, and
d- and l-pseudoephedrine), in addition to the two racemates. The chiral analysis
of ephedrine or pseudoephedrine isomers can also help in the determination of
the manufacturing process of illicit methamphetamine.
All manufacturing methods starting from l-ephedrine or d-pseudoephedrine
produce (+)-(S)-methamphetamine as the single optical isomer, which is at least
twice as potent as the racemic mixture produced by reactions starting from P-2-P.
Hydriodic acid-red phosphorus route: this is typically carried out by heating
ephedrine or pseudoephedrine with red phosphorus and hydriodic acid. The
reaction mixture is then filtered, basified and extracted into a solvent. The result-
ing methamphetamine base is an oily liquid, commonly referred to as “meth oil”.
The hydrochloride salt is crystallized from this liquid using ether/acetone and
hydrochloric acid. Alternatively, hydrogen chloride gas (from a cylinder, an
aqueous solution, or generated using sulphuric acid and sodium chloride) is
bubbled through the meth oil causing the hydrochloride salt to precipitate out of
the solution.
Hl and red phosphorus can be replaced by iodine and hypophosphoric acid
(sodium hypophosphate), or by water and iodine. In rare occasions, the reaction
mixture, sometimes known as “ox-blood”, is used without further purification,
mostly by injection. The red coloured mixture, caused by an excess of iodine,
contains “meth oil” and different impurities related to the Hl/red P route.
Typical impurities found in samples produced by reductions involving Hl/red
P or iodine/hypophosphoric acid are ephedrine or pseudoephedrine, aziridines
and dimethylnaphthalenes. Aziridines cannot be considered as route-specific
impurities since they can be also produced from chloroephedrine by halogen
elimination and ring closure (Emde method), or from an oxime intermediate and
N-hydroxymethamphetamine.
Birch reduction: this proceeds via a dissolving metal reduction of ephedrine

or pseudoephedrine in the presence of ammonia. The reaction involves mixing the
ephedrine or pseudoephedrine with anhydrous ammonia gas and either sodium or
lithium metal. The mixture is then allowed to stand until the ammonia has
evaporated. Isolation of the meth oil is carried out by direct solvent extraction
and filtration. The reaction product is further purified by formation of the hydro-
chloride salt and re-crystallisation. In illicit practice, Birch reduction is usually
completed in a one-step reaction using widely available ammonia, and lithium
strips from batteries. Despite this, Birch reduction usually produces a very “clean”
end-product. Several route-specific impurities such as N-methyl-1-(1-(1,4-cyclo-
hexadienyl))-2-propanamine are reported in the literature. The reaction involving
anhydrous ammonia is hazardous and explosions in clandestine laboratories are
not uncommon.
Emde method: ephedrine or pseudoephedrine are typically reacted with thionyl
chloride to give the intermediate chloroephedrine, which is then hydrogenated over
a platinum or palladium catalyst to yield methamphetamine. In GC-based analyti-
cal schemes, the chloroephedrine intermediate is rarely found as an impurity,
because it decomposes during analysis to form aziridines. Chloroephedrine also
decomposes rapidly during basic extraction of methamphetamine.
C. SYNTHESIS OF RING-SUBSTITUTED ATS
The most commonly encountered methylenedioxy-type ATS is MDMA, and

occasionally MDEA and MDA. In general, the synthesis routes used for MDMA
are applicable, with minor modifications, to other methylenedioxy-substituted
analogues.
The key precursor used for such syntheses is 3,4-methylenedioxyphenyl-2-
propanone (also known as 3,4-MDP-2-P, 3,4-methylenedioxy-phenylacetone,
piperonyl methyl ketone, or PMK). 3,4-MDP-2P is a commercially available,
internationally controlled precursor.
MDMA can also be synthetised from safrole (3,4-methylenedioxyallylben-
zene), either directly, or via isosafrole obtained by isomerization of safrole. Safrole
itself is commercially available, or can be extracted from sassafras oil and other
safrole-rich essential oils or plant parts. Piperonal (heliotropin, 3,4-methylene-
dioxybenzaldehyde), a widely used industrial chemical, is another alternative
precursor for the synthesis of 3,4-MDP-2-P.
The most direct method for MDMA synthesis is via reductive amination of
3,4-MDP-2-P with methylamine and hydrogen gas over a platinum catalyst (cata-
lytic metal reduction). The reduction can also be achieved by dissolving metal
reduction using aluminium amalgam (aluminium foil and mercuric chloride), or
by metal hydride reduction using sodium cyanoborohydride (see figure V).
Substituting ethylamine for methylamine produces MDE; ammonia gas
produces MDA, while dimethylamine produces MDDMA.
Figure V. Reductive amination used in illicit MDMA manufacture
O H2N O
+ CH3
O N
O O
3,4-MDP-2-P methylamine imine
H2/Pt,
Al/Hg, or
NaCNBH 3
N
O
MDMA
Analogous to illicit amphetamine manufacture, a method commonly used in

illicit manufacture of MDMA is the Leuckart method. 3,4-MDP-2-P and N-methyl-
formamide are reduced using formic acid. The resulting intermediate N-formyl-
MDMA is hydrolized by refluxing with strong acid or base to produce MDMA.
The nitropropene method has become popular since the early 1990s. It
involves the reaction of piperonal with nitroethane in the presence of basic cata-
lyst, commonly n-butylamine. Various procedures for the production of the inter-
mediate phenyl-nitropropene are reported in the literature, but typically a mixture
of piperonal and nitroethane is simply allowed to stand for a few days in the dark.
Alternatively, piperonal and nitroethane are refluxed in acetic acid and ammonium
acetate.
The intermediates formed in these reactions are very characteristic in appear-
ance and usually precipitate out of the reaction solution as bright yellow crystals.
To produce MDA, the intermediate is usually reduced with lithium aluminum
hydride. For the synthesis of MDMA, MDEA or other ATS, the nitropropene
intermediate is converted into 3,4-MDP-2-P, which is then reduced by one of the
reductive amination methods described previously. The nitropropene/nitrostyrene
intermediates are bright yellow or bright orange crystalline substances.
MDMA is also commonly manufactured using the so-called “bromosafrole”
route. The reaction proceeds via bromination of safrole with hydrobromic acid at
low temperature, followed by treatment with methylamine to form the final prod-
uct. The yield will depend on the water content of the reaction mixture.
Substitution of methylamine with other amines produces different MDMA-type
products (e.g., MDA, MDEA, or MDDMA).
Methoxyamphetamine-type drugs are typically synthesized using the appro-
priate ring-substituted aldehyde and nitroethane, while for mescaline, 2C-B, and
other ring-substituted phenethylamines, nitromethane is used.
2C-B is manufactured by reacting 2,5-dimethoxybenzaldehyde and nitro-

methane, followed by LiAlH4 reduction to form the 2,5-dimethoxyphenethylamine.
2,5-dimethoxyphenethylamine is then brominated to form the final product.
VI. QUALITATIVE AND QUANTITATIVE
ANALYSIS OF ATS
Generally, in attempting to establish the identity of a controlled drug in sus-

pected material, the analytical approach must entail the determination of at
least two uncorrelated parameters. It is recognized that the selection of these
parameters in any particular case would take into account the drug involved
and the laboratory resources available to the analyst. It is also accepted that
unique requirements in different jurisdictions may dictate the actual prac-
tices followed by a particular laboratory.
A. PRESUMPTIVE TESTS
Presumptive tests are fast screening procedures that usually consist of two or three
independent tests. They are designed to provide an indication of the presence or
absence of drug classes in the test sample and quickly eliminate negative sam-
ples. Good presumptive test techniques, as all analytical techniques, maximize the
probability of a “true” result, and minimize the probability of a false positive.
However, presumptive tests are not considered sufficient for drug identification
and results must be confirmed by additional laboratory tests.
In recent times, presumptive tests are more often used as field tests, although
they are also carried out in laboratories as a first screening procedure. For ATS
screening, colour tests, or spot tests, are typically used, although immunoassay
tests and a number of fast and portable instrumental techniques are also available.
Instrumental screening methods such as ion mobility spectrophotometer (ion-scan),
portable mass spectrometer, FTIR or Raman spectrometer, recently have gained
popularity. Many commercial test kits for ATS screening are available, however,
they should be evaluated “in house” for specificity and sensitivity.
1. COLOUR TESTS
Colour tests are usually the simplest and quickest chemical test that an analyst
can apply to a sample. Most colour tests are quite sensitive; thus, only minute
quantities of sample are necessary to complete a successful test, and often the
17
best results are obtained with the smallest of sample quantities, frequently less
than one mg.
Because samples may vary in purity (ATS concentration), and unrelated sub-
stances may be present, the colours exhibited by these tests should be interpreted
with care. In addition, the subjective aspect of colour evaluation should always
be borne in mind.
Colour test techniques
Several different reagents are typically employed for colour testing of ampheta-
mine type substances and their ring substituted analogues. The most important
colour tests for these substances are Marquis, Simon’s and Chen’s test. The
Marquis test allows the distinction between amphetamine and its ring-substituted
analogues. Simon’s test is generally used as a test for secondary amines, such as
methamphetamine and secondary ring-substituted amphetamines, including
MDMA and MDE. However, other secondary amines, for example, diethylamine
and piperidine, may give similar colours. In general, colours are intense but may
fade quickly in the presence of some impurities. For these reasons, it is essential
for the analyst to confirm Simon’s test results by performing a supplementary test,
e.g., the Marquis test. Chen’s test is used to distinguish ephedrine, pseu-
doephedrine, norephedrine, phenylpropanolamine and methcathinone from
amphetamine and methamphetamine, which do not react with Chen’s test reagent.
A fourth test, the gallic acid test, provides a simple means for the distinc-
tion of MDMA, MDA and MDEA from amphetamine or methamphetamine,
because it reacts specifically with methylenedioxy-substituted aromatic com-
pounds. Precursors containing the methylenedioxy-substructure, such as safrole
and isosafrole also react.
Methods
Preparation of reagents is described in annex II. Reagents should be prepared

freshly.
Marquis test
쐌 Place a small amount (1-2 mg of powder, or 1-2 drops of a liquid) of
the suspected material in a depression on a spot plate.
쐌 Add one drop of Marquis Reagent 1, then one drop of Reagent 2, and
stir.
쐌 Observe the colour of the mixture.
Simon’s test
Qualitative and quantitative analysis of ATS 19
쐌 Add one drop of Simon Reagent 1 and stir.

쐌 Add one drop of Simon Reagent 2, and then one drop of Reagent 3.
Chen’s test
쐌 Add 2 drops of Chen Reagent 1.
쐌 Add 2 drops of Chen Reagent 2, then add 2 drops of Reagent 3 and stir.
Gallic acid test

the suspected material in a small test tube.
쐌 Add one drop of Gallic acid Reagent.
Results
Table 1 provides results of the three main colour tests for the most commonly
encountered amphetamine-type stimulants and their ring-substituted analogues.
Because the gallic acid test is mainly used to identify, generally, the
methylene-dioxy ring substituent and not individual ATS with that sub-structure,
results are not included separately, for individual substances, in the table. A bright
to dark green colour indicates the presence of MDA, MDMA, MDE, N-hydroxy-
MDA or MMDA. In some cases, e.g., MDE and N-hydroxy-MDA, the green
colour may change to brown during the course of the test.
Table 1. Colour test results
Compound Marquis reagent Simon reagent Chen reagent
Amphetamine Orange, slowly NR* NR*

turning brown
Cathinone NR NR* Gradually turns to
yellow or orange
Dimethylamphetamine Orange NR* NR*
Ephedrine Pseudoephedrine NR NR* Purple
N-Ethylamphetamine Yellow, turning brown
Methamphetamine Orange, slowly Deep blue NR*
turning brown
Methcathinone NR slightly blue, spot- or Gradually turns to
ring-like precipitate yellow or orange
Norephedrine NR NR Purple
2C-B Yellow --> green NR* NR*
2C-T-2 Light pink, orange NR*
2C-T-7 NR NR*
Table 1. (continued)
Compound Marquis reagent Simon reagent Chen reagent
DMA green --> dark green NR*

DOB Yellow --> green NR* NR*
DOET yellow brown NR*
FLEA Dark blue/black
MBDB Dark blue/black Deep blue NR*
MDA Dark blue/black NR* NR*
MDDM Dark blue/black
MDEA Dark blue/black (Deep) blue --> NR*
brown
MDMA Dark blue/black Deep blue NR*
MDOH Dark blue/black
MMDA Purple NR* NR*
4-MTA NR NR*
PMA NR --> light green NR*
STP / DOM Yellow NR* NR*
TMA Orange NR*
Note: NR = no reaction
*The colour of the reagent should be considered as negative.
Analytical notes
(a) ATS specific

Because ATS, especially ring-substituted analogues and methamphetamine in Southeast
Asia, are frequently encountered in the form of brightly coloured tablets, the result of
colour tests may be masked, or a change of the colour test result may occur.
Although a wide variety of colours are used for the production of ATS tablets, most
colours are soluble in water, and their solubility may be manipulated by changing the
pH of the solution. In such cases, therefore, the analyst should adjust the extraction
procedure and eliminate the colour altogether before proceeding to the colour test itself.
In cases, when a colour test cannot be clearly interpreted due to presence of a tablet
dye, the following procedure will often produce acceptable results:
Place a small amount (approximately 10 mg) of the sample into a small test tube.
Add approximately 1 ml of methanol (or 1 ml of a 4:1 mixture of methanol:methyl-
ene chloride). After filtering through glass wool, evaporate to dryness. Reconstitute
the
sample in a minimum amount of water, and then proceed with the colour test by care-
fully depositing the aqueous sample solution on a spot plate and adding colour reagent.
Since the sample is already diluted, 3 reagent drops per one drop of sample solution
will be sufficient.
The presence of diluents and adulterants may also disturb colour reactions and result
in false negative test results. While Simon’s test can lead to false negative results when
adulterants or diluents are present in ATS samples, the Marquis test is less sensitive
to adulterated samples and is, therefore, preferable when the concentration of ATS in
the sample is very low.
(b) General
The colours described are subjective judgements due to individual perception of
colours. Because of this, subjective aspect of colour evaluation, it is necessary for
each analyst to test appropriate reference standards in order to ensure that he or she
can recognize each colour test result. Similarly, it is advisable to carry out a blank
test without the target substance to ensure familiarity with the colour of the reagent.
When preformed properly, a negative colour test is generally quite reliable in estab-
lishing the absence of a target compound; however, positive results are only pre-
sumptive indications of the possible presence of a compound. Many other
compounds, often harmless and uncontrolled by national legislation or international
treaties, may give similar colours with a given colour test reagent.
Therefore, it is mandatory for the analyst to confirm a positive colour test for any
legally controlled compound by the use of additional laboratory tests.
To eliminate the possibility of a false positive result due to a contaminated spot
plate, it may be advantageous to place the reagent onto the spot plate, and then add
a small quantity of the sample to the reagent.
Further reading
United Nations (1995). Rapid testing methods of drugs of abuse, Manual for use by natio-
nal law enforcement and narcotics laboratory personnel (ST/NAR/13/Rev.1)
S. A. Johns, A. A. Wist and A. R. Najam (1979). Spot tests: a colour chart reference for
forensic chemists, J. Forensic Sci., vol. 24, pp. 631-649.
E. Jungreis (1985), Spot test analysis, Clinical, environmental, forensic and geochemical
applications, John Wiley & Sons, New York-Chichester-Brisbane-Toronto-Singapore.
A. C. Moffat, M. D. Osselton and B. Widdop (eds.) (2004), Clarke’s Analysis of Drugs
and Poisons, 3rd ed., Pharmaceutical Press, London-Chicago.
C.L. O’Neil et al. (2000), Validation of twelve chemical spot tests for the detection of
drugs of abuse, Forensic Sci. Int., vol. 109, pp. 189-201.
R.A.Velapoldi and S.A. Wicks (1974), The use of chemical spot test kits for the presump-
tive identification of narcotics and drugs of abuse, J. Forensic Sci., vol. 19, pp. 636-654.
2. ANION TESTS
Anion testing for forensic purposes typically makes use of solubilities combined
with selected reactions where results are determined by the presence or absence,
and solubility, of a precipitate.
The solubility of different ATS and their salts in water and several common
solvent systems are described below.
Amphetamine and its salts
Base Hydrochloride Phosphate Sulphate
Water Slightly soluble Soluble Soluble Soluble

Methanol or ethanol Soluble Soluble Slightly soluble Slightly soluble
Diethyl ether Soluble Insoluble Insoluble Insoluble
Chloroform Soluble Soluble Insoluble Insoluble
Methamphetamine and its salts
Base Hydrochloride
Water Slightly soluble Soluble

Methanol or ethanol Soluble Soluble
Diethyl ether Soluble Insoluble
Chloroform Soluble Soluble
Ring-substituted ATS and their salts
The free bases of ring-substituted ATS are generally insoluble in water and soluble in ethanol, diethyl
ether, chloroform and other organic solvents. Their hydrochloride salts are soluble in water and ethanol,
slightly soluble in chloroform, and insoluble in diethyl ether. Solubilities of individual substances of
this group depend on the specific ring-substituted ATS in question.
Methods
All reagents should be prepared according to an established procedure. Details of

the preparation of reagents are described in annex II.
Silver nitrate test

The unknown ATS sample is dissolved in several drops of deionized water and
treated with 1-2 drops of AgNO3 solution. The results for common anions are
listed below. Because other anions can also give similar results, additional tests
or familiarization of the test limitations should be performed.
Chloride: Forms a white curdy precipitate that is insoluble in concentrated nitric

acid. After washing with water, the precipitate is soluble in dilute ammonia solu-
tion, from which it can be re-precipitated by the addition of nitric acid.
Bromide: Forms a pale yellow to cream coloured precipitate that is insoluble in

nitric acid. After washing with water, the precipitate very slowly soluble in dilute
ammonia solutions and soluble in concentrated ammonia solutions. It can be re-
precipitated from both solutions by the addition of nitric acid.
Iodide: Forms a bright yellow precipitate that is slightly soluble in a concentrated

ammonia solution but soluble in a thiosulfate solution.
Sulphate: Forms a light coloured crystalline precipitate that can easily be identi-
fied by placing the testing solution on a microscope slide and looking for the
characteristic "diamond" shaped silver sulphate crystals.
Phosphate: Forms a light yellow precipitate, which is soluble in a dilute ammo-

nia solution, or cold nitric acid.
For sulphate and phosphate salts, additional specific tests may be performed:
Sulphate salt test

The unknown ATS sample (about 100 mg) is dissolved in water and treated with
a solution of barium chloride. A white precipitate, which is insoluble in hydrochlo-
ric acid, indicates the presence of a sulphate salt.
Phosphate salt test

The unknown ATS sample (about 100 mg) is dissolved in a solution made of
equal volumes (for example, 1ml each) of nitric acid solution (10% v/v) and
ammonium molybdate solution (10% w/v). With gentle heating, formation of a
bright canary-yellow precipitate, which is soluble in ammonia solution, indicates
the presence of a phosphate salt.
Analytical notes
Since all anion tests are carried out in aqueous solutions, water-solubility of the
ATS salts is a pre-condition to meaningful results.
Washing the precipitate with water before performing the test for dissolution of the
precipitate is critical to remove any soluble (non-precipitated) anion.
Further reading
McKibben, T., Chappell, J. S., Evans, H., Mausolf, N., Analyses of Inorganic Components
Found in Clandestine Drug Laboratory Evidence, J. Cland. Lab. Invest. Chem. Ass., 5(4),
1995, 19-33.
3. MICROCRYSTAL TESTS
Microcrystal tests are quick, simple, and extremely sensitive tests for the identi-
fication of substances and their optical isomers. They involve formation of crys-
tals from the reaction of the target compound with a chemical reagent, followed
by the analysis of the resulting crystals by means of a polarizing microscope and

comparison with reference material, usually photographs of known crystals.
Methods
The simplest form of the test consists of adding a drop of suitable reagent to the
test substance, followed by observing and analyzing the crystals formed under the
polarizing microscope.
In order to maintain an accurate record, the characteristic features of the crys-
tals should be described. The most accurate record of the test results is by photo-
graphs. If a photograph is not available a sketch of crystal forms is helpful.
Methods and procedural details for microcystal tests of ATS are described
in chapter VI.G.2. Descriptive terms for crystal forms and photographs of crystals
of major ATS as well as basic instrument and equipment requirements are given
in annex III.
Further reading
Cunningham, M. D. (1973). Rapid and sensitive technique for the differentiation of the optical
isomeric forms of methamphetamine and amphetamine, Microgram, vol. 6, No. 6, pp. 87-95.
Fulton, C. C. (1969). Modern Microcrystal Tests for Drugs. Wiley-Interscience, A Division
of John Wiley & Sons, New York-London-Sydney-Toronto.
Ono, M., Microcrystal Test, Japan, 1996. (provides a comprehensive introduction to the
technique of microcrystal tests, and includes photographs of microcrystal test results of 39
ATS and their precursors).
B. THIN LAYER CHROMATOGRAPHY (TLC)*
TLC has become one of the most commonly used techniques for the separation
and identification of illicitly manufactured drugs. It is rapid (an analysis is rarely
longer than thirty minutes), sensitive (sub-milligram quantities of analyte
required), enormously flexible in both the stationary and the mobile phase, and
thus amenable to a wide variety of substances, in base and salt form, ranging from
the most polar to the most non-polar materials. It is also amenable to a variety
of visualization techniques, and it is inexpensive.
Despite the obvious advantages of TLC, in many countries, it is not accepted
as a single technique for drug identification.
*For more standardized TLC systems, see: Thin-layer chromatographic Rf values of toxicologi-
cally relevant substances on standardized systems, second, revised and enlarged edition, Report XVII
of the DFG Commission for clinical-toxicological analysis, Special issue of the TIAFT Bulletin, VCH
Verlagsgesellschaft mbH, 1992.
TLC plates (stationary phases)

Coating: Silica gel G with a layer thickness of 0.25 mm, and containing an inert
indicator, which fluoresces under UV light wavelength 254 nm
Note: Plates prepared by the analyst must be activated before use by placing them into an oven for
at least 10 to 30 minutes at 120°C. Plates are then stored in a grease-free desiccator over blue silica
gel. Heat activation is normally not required for chemically bonded layers (commercial plates).
Typical plate sizes: 20x20 cm, 20x10 cm, 10x5 cm (the 10x5 cm plate should be
used with the 10 cm side vertical in the TLC tank)
Solvent systems (mobile phases)

System A: Methanol 100
Concentrated ammonia 1.5
System B: Ethyl acetate 85

Methanol 10
Concentrated ammonia 5
System C: Cyclohexane 75
Toluene 15
Diethylamine 10
Methods
Recommended methods and selected results are provided below, but it remains
the responsibility of the analyst to familiarize him/herself with the specific results
of individual ATS.
Solvent systems
Prepare developing solvent systems as accurately as possible by use of pipettes
and measuring cylinders. Leave the solvent system in the TLC tank for a time
sufficient to allow vapour phase saturation to be achieved prior to the analysis
(with adsorbent paper-lined tanks, this takes approximately 5 minutes).
Preparation of ATS standard and sample solutions

The form of standards and samples, salt or base, is unimportant. Either form will
be satisfactory. Because of the basic nature of the developing solvents, the
compounds migrate as free bases.
ATS standard solutions: Standard solutions of ATS should be prepared at a con-

centration of approximately 2 mg/ml in methanol. They must be stored in a dark
and cold place.
ATS sample solutions (unknown ATS sample): Sample solutions should be pre-
pared at a concentration of approximately 5mg/ml in methanol. In cases, where
the ATS purity is suspected to be very low due to adulteration, it may be neces-
sary to prepare more concentrated sample solutions (ten-times more concentrated
solutions are recommended as a starting point).
For ATS samples in other forms than powder, the sample solutions should
be prepared as follows:
Tablets: Grind a representative number of tablets (following general sam-

pling plans) to a fine powder and prepare a solution as for powders.
Capsules: Remove the contents of a representative sample of capsules (fol-
lowing general sampling plans) and prepare a solution as for powders.
Aqueous solutions: Spot directly, or the equivalent of 5mg/ml, if the concen-
tration of the ATS is known.
Spotting and developing

Place both a 1 애l and a 5 애l spot of sample solution, together with 2 애l of the
standard solution(s) onto the TLC plate (preferably, also a solvent spot as a neg-
ative control should be applied to the plate). Spotting must be done carefully,
without damaging the plate’s surface.
The starting point of the run, i.e., the “spotting line,” should be 2 cm from
the bottom of the plate. The spacing between applications of sample (spotting
points) should be at least 1 cm, and spots should not be placed closer than 1.5 cm
to the side edge of the plate. To avoid diffuse spots during development, the size
of the sample spot should be as small as possible (울 2 mm).
Allow spots to dry, and place plate into solvent-saturated TLC tank (satura-
tion of the vapour phase is achieved by using solvent-saturated pads or filter paper
as lining of the tank). Remove plate from the development tank as soon as the
solvent reaches the development line marked beforehand; otherwise, diffuse spots
will occur.
Visualization/detection
Plates must be dried prior to visualization: The solvent can be allowed to evap-
orate at room temperature, or removed with a hot air blower. If hot air is used,
care must be taken because of the volatility of the ATS free bases. It is impor-
tant for proper colour development that all traces of ammonia be removed from
the plate.
The following is a selection of visualization methods. Based on the results
of the presumptive tests, anticipated ATS should be targeted using one or a com-
bination of the following methods and reagents:
Method/Visualization reagent Target analytes and results
A. UV light at 254 nm Universal method. Many substances, including ATS, give

purple spots on an otherwise green-fluorescent plate
B. Ninhydrin reagent Many primary and secondary amines attached to an
aliphatic carbon atom, such as amphetamine and
methamphetamine, result in violet or pink spots.
C. Acidified potassium Sensitive general reagent. Most primary and secondary
iodoplatinate reagent amines give light blue spots.
D. Fast Black K Primary and secondary amines give spots varying in
colour from violet (primary amines) to orange or
orange-red (secondary amines).
E. Marquis reagent Distinction between unsubstituted and ring-substituted
ATS
F. Fluorescamine reagent (Fluram) Sensitive reagent for primary amines. Recommended for
the detection of low concentrations of primary amines.
G. Simon reagent General reagent for secondary amines (ephedrine and
pseudoephedrine do not react)
H. Dragendorff ragent General reagent for alkaloids and nitrogenous bases
Key:
Method/Visualization reagent
A. UV light
Observe the dried plate under UV light at 254nm and 366nm.
B. Ninhydrin reagent
Prepare a 10% solution in ethanol.
Spray the plate with the ninhydrin reagent and heat in an oven at 120°C for at least 15 minutes.
Violet or pink spots are given by primary amines such as amphetamine and secondary amines
such as methamphetamine. Ephedrine also produces a violet spot.
C. Acidified potassium iodoplatinate reagent
Dissolve 0.25g platinic chloride and 5g potassium iodide in water and make up to 100 ml.
Add 2 ml of concentrated hydrochloric acid.
Spray the plate with acidified potassium iodoplatinate solution and observe any coloured spots
Amphetamine and methamphetamine give dirty grey-violet-brown spots on a pink background.
The solution may also be used to overspray plates that have previously been sprayed with
ninhydrin.
D. Fast Black K
Solution A: Prepare 1% solution of Fast Black K salt in water [2,5-Dimethoxy-4-((4-nitro-
phenyl)azo)benzene diazonium tetrachlorozincate (2:1)]
Solution B: 1N NaOH
Spray the plate with solution A and observe any coloured spots. Secondary amines such as
methamphetamine and MDMA produce spots immediately. Overspraying with solution B pro-
duces coloured spots for amphetamine and other ring-substituted ATS. Air dry the plates and
spray once more with solution A. This produces more intensely coloured spots. The colours
vary from violet for primary amines to orange or orange-red for secondary amines such as
methamphetamine and MDMA.
E. Marquis reagent
Add 8-10 drops of 40% formaldehyde solution to 10 ml of concentrated sulphuric acid. Prepare
fresh prior to each use.
Spraying with Marquis reagent is not recommended because of the concentrated sulphuric acid
involved. However, it provides additional information useful for differentiating between ATS,
for example, after detection with ninhydrin. To that end, drop the Marquis reagent with a
Pasteur pipette on the spots already detected.
F. Fluorescamine reagent (Fluram)
Dissolve 10 mg fluorescamine in 50 ml acetone. Prepare daily
Spray the plate with the fluorescamine reagent. Air dry it with a hot air blower. Observe the
plate under a UV light at 366 nm. Amphetamine gives a bright yellow fluorescent spot.
Methamphetamine is not detected. (For stabilization on 366 nm, spray with 10% v/v solution
of trietylamine in dichloromethane).
G. Simon reagent
Dissolve 100 mg of sodium nitroprusside and 2 g of sodium carbonate in 10 ml of water (i.e.,
an aqueous solution containing sodium nitroprusside at a concentration of 1%, and sodium car-
bonate at 20%). Prepare reagent freshly before use.
Spray the plate with the Simon reagent. Place the plate in an empty developing tank along
with a beaker containing acetaldehyde. Cover the tank. The acetaldehyde vapour will cause a
methamphetamine spot to become an intense blue colour. (This modified method improves the
sensitivity for methamphetamine to 0.1 애g (LOD). Primary amines cannot be detected, because
of the system’s low sensitivity for this group of substances, and the interference with the back-
ground colour when ammonia is used in the developing solvent.)
H. Dragendorff reagent
Stock solution: Dissolve 0.85 g bismuth subnitrate (basic) in 10 ml acetic acid. Dilute to 50 ml
with water and add 8 g of potassium iodide in 20 ml water
Spray the plate with a solution prepared from 1 ml Dragendorff stock solution, 2 ml acetic
acid and 10 ml water. Colours vary from orange to violet.
Interpretation
After visualization, mark spots (e.g., by pencil), and calculate retardation factor (Rf) values:
Migration distance: from origin to centre of analyte zone (spot)

Rf =
Development distance: from origin to solvent front
It is very common to express retention factors as Rf x 100, referred to as hRf.
Results
Compare colours and Rf values of the unknown ATS sample with those of the
authentic ATS reference standards that were run simultaneously on the same plate.
Rf values for some of the most common ATS are given in Table 2.
Table 2. Rf values of commonly encountered ATS and adulterants
TLC system*
ATS name A B C
Amphetamine 0.48 (0.43)** 0.37 (0.43) (0.20)

Cathinone 0.66 0.56
DOB 0.37 0.32 (0.13)
DOET 0.36 0.32 (0.24)
DMA 0.37 0.33 (0.19)
N-Ethylamphetamine 0.47 0.37 (0.47)
Methamphetamine 0.35 (0.31) 0.22 (0.42) (0.28)
MDA 0.36 (0.39) 0.33 (0.42) (0.18)
TLC system*
ATS name A B C
MDMA 0.31 (0.33) 0.21 (0.39) (0.24)

MMDA 0.40 0.31
PMA 0.41 (0.73) 0.33 (0.43) (0.23)
STP/DOM 0.35 (0.51) 0.31 (0.41) (0.15)
TMA 0.35 0.20
Ephedrine (0.30) (0.25) (0.05)
Caffeine (0.52) (0.52) (0.03)
*Solvent system: A, B or C; TLC plate: Silica gel G with layer thickness of 0.25 mm
System A: Methanol: concentrated ammonia (100:1.5)
System B: Ethyl acetate: Methanol: concentrated ammonia (85:10:5)
System C: Cyclohexane: Toluene: Diethylamine (75:15:10)
**Rf values in brackets were obtained using Silica plates impregnated with methanolic KOH (0.1 mol/l).
Analytical note
Because small changes in TLC plate composition and activation, in solvent systems, tank
saturation or development distance can result in significant changes in the Rf values, the
values provided should only be considered as an indication of the chromatographic
behaviour of the ATS and adulterants listed. It is essential that ATS reference standards
be run simultaneously on the same plate. Alternatively, reproducibility can be significantly
enhanced by the use of reference compounds and corrected Rf values (Rfc).
For identification purposes, both the Rf values and the colour of the spots after spraying
with different visualization reagents should always be considered.
Further reading
Fried and J. Sherma (Eds.), Practical Thin-Layer Chromatography, A Multidisciplinary
Approach, Boca Raton Press, 1995.
Jork et al., Thin-Layer Chromatography, Reagents and Detection Methods, Weinheim,
VCH, vol. 1 (1990), vol. 2 (1992).
Neumann, H. (1987). Nachweis und Identifizierung von Phenylethylaminen (Stimulantien
und Halluzinogene), Sci. Pharm., vol. 55, 1-11.
Ojanperä, I., Wähälä, K., and Hase, T. A. (1990). Fast Black K salt: a versatile thin-layer
chromatographic visualization reagent for the differentiation of aliphatic amines, Analyst,
vol. 115, pp. 263-267.
Stead, A. H., Gill, R., Wright, T., Gibbs, J. P., Moffat, A. C. (1982), Standardized thin-
layer chromatographic systems for the identification of drugs and poisons, Analyst, vol. 107,
pp. 1106-1168.
C. GAS CHROMATOGRAPHY (GC)—FLAME IONIZATION

DETECTOR (FID)
For the GC analysis of ATS, the general principles of the techniques apply. Today,
the GC instrument of choice for routine analytical work is the narrow bore
capillary gas chromatograph, using capillary columns with internal diameters
between 0.2 and 0.32 mm.
It is recognized that there are laboratories, which for a variety of reasons,
may wish to maintain a packed column system. For those laboratories, a method
using packed columns was described in an earlier edition of this manual. GC
procedures utilizing a megabore capillary column (0.53 mm internal diameter)
represent a means to improve on resolving power compared to packed columns,
and are more robust than narrow bore capillary column systems. Older GC
systems that are designed for packed columns can be converted for use with
megabore columns.
Methods
1. QUALITATIVE ANALYSIS
ATS standard solutions: weigh approximately 25 mg of ATS standard salt(s)* of

interest into a 25 ml volumetric flask and make up to the mark with water. Pipette
an aliquot of 1 to 5 ml of this solution into a 10 ml glass stoppered test tube.
Add drop-wise a 5% solution of sodium hydroxide until pH 10. Then add 5 ml
of extracting solvent**.
Stopper and invert the test tube at least 10 times or vortex for 1 min and let
stand until layers separate.*** Using a Pasteur pipette, transfer the solvent layer
(e.g., chloroform) through anhydrous sodium sulphate layer into a GC vial.
Inject 1-2 애l of the solvent layer into the GC.
ATS sample solutions (unknown ATS sample): weigh 25 to 150 mg of sample,

depending on the anticipated purity, to obtain a final concentration of about
*Occasionally, ATS standards can be obtained in the base form. In those cases, extraction is not
required. In general, however, it is important that the form of standards and samples be always the
same.
**All analytes must be completely soluble in the extraction solvent. The extraction solvent must
be immiscible with aqueous layer. Suitable solvents include n-hexane, chloroform, methylene chloride
or butyl acetate.
***When chloroform is used as extracting solvent, emulsions may form. In such cases, addition
of NaCl improves the extraction rate by breaking the emulsion. If modern shakers are used and the
mixture is then centrifuged for separation of the two layers, the formation of emulsions normally does
not occur.
1 mg/ml of analyte salt, into a 25 ml volumetric flask and make up to the

mark with water. The anticipated sample purity is determined empirically.*
Pipette an aliquot of 1 to 5 ml of this solution into a 10 ml glass stoppered
test tube. Add drop-wise a 5% solution of sodium hydroxide until pH 10. Then
add 5 ml of the extracting solvent (e.g., chloroform).
stand until the layers separate. Using a Pasteur pipette, transfer the solvent layer
through anhydrous sodium sulphate layer into a GC vial.
Inject 1-2 애l of the solvent layer into the GC.
If quick sample throughput is required, samples may be taken up directly
in ethanol/aqueous ammonia (99:1), and injected onto the gas chromatograph.
Using this method, the condition of the injector and column may deteriorate
more quickly than with extracted samples (Note: This method is not suitable for
quantitative analysis since it is hard to produce good chromatography in the
presence of ammonia).
GC operating conditions
Detector: FID (or NPD, if available/desired)
Column: DB-5 (5% phenyl 95% dimethylpolysiloxane),
DB-1 (100% dimethyl-polysiloxane), or equivalent
Length: 10-30 m, ID 0.20-0.53 mm
Film thickness: 0.10-0.50 애m
Carrier gas:** Nitrogen, helium or hydrogen, at approx.
0.8ml/min. (N2) or 1-1.2 ml/min. (He or H2)
Split ratio: 20:1 to 50:1
Column temperature: initial temperature has to be low enough
(e.g., 60-90°C) to account for high volatility of
ATS bases, e.g.: 60°C, hold for 0.5 min.,
to 280°C, at a rate of 12°C/min., hold final
temperature for 30 min.
Injector temperature: 210-250°C
Detector temperature: 310°C
Results
Identification is accomplished by comparing the retention time of the analyte

with that of a reference standard. The elution order is as follows:
*Determination of sample purity may be done based on chemist’s experience, or using the fol-
lowing rough method: Take 100 mg of sample and dissolve in 2-3 ml of chloroform. Filter the solu-
tion, collect the insolubles, dry and weigh. The soluble amount (i.e., original weight minus dry
insolubles) is the anticipated sample purity. Note, however, that this method may result in a lower
than actual anticipated sample purity for salts that are not soluble in chloroform (see chapter VI.A.2,
on “anion tests”, above).
**The gas flow depends on column ID; pressure gradient programming can be used if available.
amphetamine < methamphetamine < pseudoephedrine < ephedrine < PMA <
PMMA < MDA < MDMA < 4-MTA < MDEA < MBDB < 2C-B.
Under the conditions described, caffeine and ketamine, which are frequently
found in ATS samples in some regions, elute after 2C-B.
2. QUANTITATIVE ANALYSIS
Three methods for the quantitative GC-FID analysis of ATS are provided below:
A single standard method (A) and two multiple standard methods (B and C).
Methods A and B do not require derivatization, while method C requires silyla-
tion. All three methods are described here for general use. Annex IV provides
examples of validated GC methods for quantitation of selected ATS.
Method A: Single standard method

Method A is suitable for quantitation of most ATS. It involves the preparation of
only one ATS standard solution in a concentration similar to the anticipated
concentration of the analyte.
Preparation of internal standard solution (IS): weigh accurately approximately

25 mg of the selected internal standard (for example, n-tetradecane or other
n-alkanes with an even number of carbon atoms, or diphenylamine) and dissolve
it in 25 ml of extracting solvent (e.g., chloroform). If the internal standard
solution is used for extraction, the target concentration should be prepared within
the instrument linear range (no more than 0.5 mg/ml).
Preparation of ATS standard and sample solutions*: the preparation of ATS

standard and sample solutions should follow the procedures outlined above for
qualitative analysis, using the internal standard solution for the extraction of both
ATS standards and samples, as follows:
(a) ATS standard solutions

Weigh accurately approximately 25 mg of ATS standard salt(s)** of interest into
a 25 ml volumetric flask and make up to the mark with water. Accurately pipette
an aliquot of 1 to 5 ml of this solution into a 10 ml glass stoppered test tube.
Add drop-wise a 5% solution of sodium hydroxide until pH 10. Then add 5 ml
of internal standard solution, accurately dispensed.
*ATS standard and samples solutions and their concentrations are designed for use with capil-
lary columns and the procedures described below. The use of alternative columns and GC systems
may necessitate changes in terms of both relative composition and concentrations of individual com-
ponents.
**If ATS standards in the base form are used, extraction is not required. In those cases, weigh
no less than approximately 10 mg of ATS standard and dissolve directly in 10 ml of accurately dis-
pensed internal standard solution. For accurate quantitation, it is important that the form of the ana-
lyte (salt or base) be the same as that of the ATS standard.
stand until layers separate. Using a Pasteur pipette, transfer the solvent layer
Inject 1-2 애l of the solvent layer into the GC. Analyze standard solution in
triplicate or more.
(b) ATS sample solutions (unknown ATS sample)

Weigh accurately 25 to 150 mg of sample, depending on the anticipated purity,
to obtain a final concentration of about 1 mg/ml of analyte salt, into a 25 ml
volumetric flask and make up to the mark with water. The anticipated sample
purity is determined empirically.
Accurately pipette an aliquot of 1 to 5 ml of this solution into a 10 ml glass
stoppered test tube. Add drop-wise a 5% solution of sodium hydroxide until pH 10.
Then add 5 ml of internal standard solution, accurately dispensed.
stand until the layers separate. Using a Pasteur pipette, transfer the solvent layer
Inject 1-2 애l of the solvent layer into the GC. Analyze unknown ATS
sample solution preferably two times or more.
Same as for qualitative GC analysis (see p. 30).
Calculations
From the multiple injections, calculate average peak area ratios of: (a) the rele-
vant ATS standard to the internal standard (ASt/IS), and (b) the unknown ATS to
the internal standard (AATS/IS).
The percentage drug content of the sample can be calculated using the general
formula:
CSt AATS/IS
ATS (%) = * * 100
CATS ASt/IS
where
ATS (%) = Content of the unknown ATS (as base or salt; see footnote **
on p. 32) in the original sample material (= sample purity)
CSt = Concentration of ATS standard solution (mg/ml), as prepared

under (a), above (= weight of pure ATS standard per milli-
litre solvent)
CATS = Concentration of the unknown ATS sample solution (mg/ml),

as prepared under (b), above (= weight of unknown ATS
sample per millilitre solvent)
AATS/IS = Peak area counts of the unknown ATS divided by peak area
counts of the internal standard (preferably, average of dupli-
cate determinations)
ASt/IS = Peak area counts of ATS standard divided by peak area counts
of the internal standard (average of triplicate determinations)
Method A can be modified from a single to a multiple standard method by sequen-

tially diluting aliquots of the ATS standard solution with the internal standard
solution using 10 ml volumetric flasks. That way, ATS standard concentrations
can be prepared, targeting the appropriate concentration within the linear range of
the instrument, and achieving a multiple-point calibration.
Method B: Multiple-standard method without derivatization

The method below is a recommended multiple-point calibration method, validated
GC methods for the quantitative analysis of ATS, with and without derivatiza-
tion, are given in annex IV.
Preparation of internal standard solution (IS)

Weigh accurately 0.3 to 0.4 g of the selected internal standard (n-tetradecane,
other n-alkanes, diphenylamine, or a structurally related ATS in base form)* into
a 500 ml volumetric flask and dilute to volume with chloroform to give an inter-
nal standard solution of 0.6 to 0.8 mg/ml.
Preparation of ATS standard solutions (GC calibration solutions)

Standard stock solutions should contain all compounds of interest in concentra-
tions of approximately 1000 mg/l. They may be kept in a closed flask in a refrig-
erator for up to one year. For the preparation of stock solutions:
(a) Accurately weigh approximately 1000 mg of the ATS salt(s) of interest

into a 1000 ml volumetric flask and make to the mark with water.
(b) Accurately pipette 5 ml of this solution into a 20 ml glass stoppered test
tube. Basify to litmus by adding a few drops of concentrated ammonia
solution. Accurately add 5 ml of chloroform.
(c) Stopper and shake well, then let stand until the layers separate. Using
a Pasteur pipette, transfer approximately 1 ml of the chloroform layer
through anhydrous sodium sulphate into a small beaker. This standard
solution must not be left to stand more than half an hour before used
for calibration.
(d) For the preparation of calibration standards for a 5-point calibration, pre-
pare the different levels as shown in the following table:
*If an internal standard in salt form (e.g., the salt of a structurally related ATS) is used, an extrac-
tion is required. In those cases, weigh no less than approximately 10 mg of ATS standard and
dissolve directly in 10 ml of accurately dispensed internal standard solution.
Preparation of multiple point calibration standards
Calibration ATS standard IS solution Approx. concentration

level solution (애l) (애l) CHCl3 (애l) of ATS-salt (mg/l)
Level 1 20 100 880 20

Level 2 40 100 860 40
Level 3 60 100 840 60
Level 4 80 100 820 80
Level 5 100 100 800 100
Inject, at least in triplicate, 1-2 애l of each level into the GC and use average val-
ues for establishment of the calibration curve.
Preparation of ATS sample solutions (unknown ATS sample)

In general, but specifically for quantitative analyses, homogenize samples before
starting any tests or sub-sampling.
(a) Accurately weigh a sufficient sample quantity into a 25 ml volumetric
flask to obtain a final concentration of approximately 0.2-1 mg/ml of
analyte. Make to the mark with water. (The amount of the sample to be
weighed will depend on the anticipated purity, as indicated by the pre-
liminary screening method. As an example, if the anticipated purity is
about 40%, the sample amount used should be approx. 60 mg.)
(b) Accurately pipette 5 ml of this solution into a 20 ml glass stoppered test
tube. Basify to litmus by adding a few drops of concentrated ammonia
solution. Accurately add 5 ml of chloroform.
(c) Stopper and shake well, then let stand until the layers separate. Using
a Pasteur pipette, transfer approximately 1 ml of this sample solution
through anhydrous sodium sulphate into a small beaker. Measure 100 애l
of sample solution, 100 애l of internal standard solution and 800 애l of
chloroform into GC sample vial.
(d) Inject 1-2 애l into the gas chromatograph. Analyze unknown ATS
sample solution preferably two times or more.
For quantitative analyses, a GC equipped with an autosampler is preferable.
Operating conditions may be the same as for qualitative analysis (see p. 30).
Calculations
The percentage drug content of the sample is calculated from the concentration
of the unknown ATS sample solution and the corresponding values from the cal-
ibration curve. With modern GC instrumentation and software, and after input by
the operator of the concentrations of the different calibration standards and the
unknown sample solution, the calibration curve will be established and calcula-
tions will be performed automatically for any single point along the curve upon
completion of the analytical run. Typically, the result will then be expressed as
the percentage content of the unknown drug in the original sample material, i.e,
as the sample purity (weight of the analyte relative to the sample weight).
Method C: Multiple-standard method with derivatization
Prepare derivatized ATS standard and sample solutions by measuring an aliquot

(e.g., 100 애l) of the liberated dried base (i.e., after having transferred sample or
standard solutions through anhydrous sodium sulphate into a small beaker; step (c)
above) together with an aliquot of 100 애l of internal standard solution, 750 애l of
chloroform and 50 애l of BSTFA (or BSTFA + 1% TMCS) into a GC sample vial.
For multiple point calibration, follow method B (see table above entitled
“Preparation of multiple point calibration standards”), using 50 애l BSTFA in each
step for the preparation of standard and sample solutions, and adding chloroform
to make up to 1 ml.
D. GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS)
GC-MS is one of the most commonly used techniques for the identification, and
recently also the quantitation, of forensic drug samples. As a hyphenated tech-
nique, it unifies the separation power and sensitivity of a GC-FID with the ana-
lyte specificity of a spectroscopic technique, providing highly specific spectral
data on individual compounds in a complex mixture of compounds without prior
separation.

Samples are prepared as described in the previously provided GC methods.
The sensitivity of the analysis and the specificity of the mass spectra of ATS
are improved by derivatization (see annex VII). Preparation of derivatives is par-
ticularly desirable when the mass spectrum of the underivatized molecule is of
low diagnostic value. Most underivatized ATS have fragment ions of low m/z
ratio, low intensity, and only one fragment ion of higher abundance (base peak).
Derivatization of ATS usually produces fragment ions of higher m/z ratio and
higher abundance. High mass ions are more specific and they have greater diag-
nostic value, since they are not affected by interfering background ions such as
column bleed or other contaminants.
Similar to the previously described GC analysis, if quick sample throughput
is required, samples may be taken up directly in ethanol/aqueous ammonia (99:1)
and injected into the GC-MS. However, in this case, the condition of the injector
and column may deteriorate more quickly than with extracted samples. For use
in GC-MS, samples of primary amines may also be taken up directly in carbon
disulfide (CS2), which results in the formation of an isothiocyanate, a derivative
that gives a more characteristic mass spectrum than the parent compounds.
GC-MS operating conditions

GC oven conditions: same as for GC analysis (Conditions from
method A, B or C can be used)
Column: same as for GC analysis, for example:
DB-5 (5% phenyl 95% dimethylpolysiloxane),
DB-1 (100% dimethylpolysiloxane),
0.25 mm x 30 m x 0.25 애m, or equivalent
Inlet
Mode: Split/Splitless
Temp: 250°C
Carrier gas: Helium, 1 ml/min
Mode: Constant flow (or constant pressure)
Detector
Ionisation mode: EI mode, 70 eV (CI mode if desired)
Transfer line temp: 280°C
Ion source temp: 230°C
Scan parameters: TIC (SIM if required), scan range: 35-450 (for
substances such as 2C-B one may start at m/z 29)
Results
Identification is accomplished by comparing the retention time and mass spec-

trum of the analyte with that of a reference standard.
All compounds identified by GC-MS and reported by the analyst must be
compared to a current mass spectrum of the appropriate reference standard, pre-
ferably obtained from the same instrument, operated under the same conditions.
There are several commercial mass spectra reference libraries available. With most
GC-MS instruments, many of those libraries are also available as an on-line option.
In general, it is, however, important to use mass spectral libraries, whether from
a commercial source or user generated, for reference purposes only.
Further reading
A single literature source for mass spectral interpretation of ATS is not available but there
are several good general literature sources, which together present reasonably comprehen-
sive data, e.g.:
Karl Pfleger, Hans H. Maurer, Armin Weber (2000), Mass Spectral and GC Data of Drugs,
Poisons, Pesticides, Pollutants and Their Metabolites: Parts I-IV, Wiley.
UNODC also has a limited collection of mass spectra related to major ATS. The collec-
tion can be accessed from the Internet or, upon request, it can also be made available on
CD-ROM.
E. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
In addition to GC, HPLC is another major separation technique commonly used

in forensic drug analysis.
For ease of sample preparation, best reproducibility and detectability, reversed
phase chromatography is recommended for the analysis of ATS and their ring
substituted analogues. The most universal and versatile column is a bonded
octadecyl silica column (C18). Column length, diameter, particle size, pore size
and carbon load should be considered before final selection of the column.
Since there are a large variety of stationary and mobile phases available to
the analyst, only guidelines are presented below.
Method
Dissolve an appropriate amount of standard or sample in the mobile phase, tar-
geting a concentration of the active component between 0.05-0.50 mg/ml. Sample
solutions should be filtered prior to analysis.
Stock and standard solutions must be prepared from reference standards.
Working standards should be within the linear range of the detector and
approximately 80-120% of the target concentration. Multiple point calibration is
desirable but a single standard method is also acceptable.
Operating conditions
Detector: Diode array detector, rapid scanning or
variable wavelength detector, UV 200-
210 nm (also use 280-290 nm for methyl-
enedioxy-substituted phenethylamines)
Stationary phase: C8 or C18 with 5 애m particle size or
smaller
Column length: 울 30 cm
Column diameter: 울 5.0 mm
Pre-column: Diameter: 2-4 mm, length: 25 mm,

reversed phase C8 or C18
Column temperature: 15-35°C (temperature control is
strongly recommended in non-
thermostated environments)
Mobile phase buffer: phosphate buffer pH 2.0-3.2
(e.g. 50 mM monobasic sodium
phosphate adjusted with phosphoric
acid). For tailing peaks, mobile
phase additives such as alkyl sulphates
or alkyl sulphonates or amines may be
required.
Mobile phase organic modifier: methanol or acetonitrile between 2%
and 20% (with higher alkyl groups, on
alkyl sulphates or alkyl sulphonates,
higher organic concentrations may be
required).
Flow rate: 0.1-2.0 ml/min.
Injection volume: 1-100 애l
Separation: Isocratic or gradient analysis should be
performed, targeting retention times of
less than 30 minutes.
Results
Identification is accomplished by comparing the retention time of the analyte with
that of a reference standard and, if available, by using multiple UV wavelengths
or diode array or rapid scanning UV detection. For ring substituted analogues such
as MDA, MDMA, and MDEA, fluorescence scans also could be used. Specificity
of the method is important, since there is always the possibility that similar com-
pounds elute at the same retention time.
A typical elution order is as follows: norephedrine, ephedrine, amphetamine,
methamphetamine, MDA, MDMA and MDEA. The separation of the ephedrine/
pseudoephedrine and norephedrine/ norpseudoephedrine pairs can be difficult, and
may require slight adjustment of the HPLC conditions.
Quantitation:
External or internal standard calibration may be used (external standard calibra-
tion is recommended especially if a valve-based injector is used in the overfill
mode). The use of peak area for HPLC quantitation is recommended, because
peak broadening (decreases in peak height) may occur as a result of deterioration
of the stationary phase, rendering peak height unsuitable for quantitation.
The specificity of detection can be enhanced by using multiple UV wavelengths

or fluorescence detection. A validated HPLC method for quantitation of ATS is
described in annex V.
Further reading
Aalberg, L., DeRuiter, J., Noggle, F. T., Sippola, E. and Clark, C. R. (2000). Chromato-
graphic and Mass Spectral Methods of Identification for the Side-Chain and Ring
Regioisomers of Methylenedioxymethamphetamine, J. Chromatogr. Sci., vol. 38, pp. 329-
337.
Clark, C. R., DeRuiter, J., Valer, A. and Noggle, F. T. (1995). Gas Chromatographic-Mass
Spectrometric and Liquid Chromatographic Analysis of Designer Butanamines Related to
MDMA, J. Chromatogr. Sci., vol. 33 pp. 328-337.
Lurie, I.S. (1995). Reversed-Phase High Performance Liquid Chromatographic Analysis of
Drugs of Forensic Interest, Chap. 4 in Analysis of Addictive and Misused Drugs,
Adamovics, J.A., (Ed.), Marcel Dekker, New York, NY, U.S.A. pp. 51-132.
Malone, J. V. (1998). HPLC Quantication of Clandestinely Manufactured Mixtures of
Amphetamine and Methamphetamine, Microgram, vol. 31, pp. 304-307.
Sadeghipour, F., Giroud, C., Rivier, L., and Veuthey, J.-L (1997). Rapid Determination of
Amphetamines by High-Performance Liquid Chromatography with UV Detection,
J. Chromatogr., vol. 761, pp. 71-78.
Sadeghipour, F., and Veuthey, J.-L (1997). Sensitive and Selective Determination of
Methylenedioxylated Amphetamines by High-Performance Liquid Chromatography with
Fluorimetric Detection, J. Chromatogr., vol. 787, pp.137-143.
Schneider, R. C., and Kovar, K. A. (2003). Analysis of Ecstasy with a Monolithic Reversed-
Phase Column, Chromatographia, vol. 57 pp. 287-291.
F. FOURIER TRANSFORM INFRARED (FTIR) SPECTROSCOPY
Infrared spectroscopy is widely employed as a qualitative and, in recent times,

also quantitative method for the determination and structural analysis of ATS.
FTIR analysis can be a particularly useful tool for the rapid screening of ATS
tablets and powders, providing indications as to the homogeneity of tablets or the
presence of mixed batches.
Sample preparation
The preferred methods for sample preparation are dissolution of the sample in an
appropriate solvent, or its suspension in an oil mull. A less desirable technique is
the halide disc method, where the sample is dispersed into finely ground potas-
sium halide (KBr or KCl) and pressed into a thin disc.
However, most forensic laboratories favour the halide disc method for two
reasons: (a) potassium halides are IR transparent in the so-called finger print region
(2000-400 cm–1); and (b) the potassium halide disc can generally be re-analysed
many times, if stored over a desiccant.
The halide disk method* consists of grinding a dry sample to a very fine
powder, then mixing about 1 mg of homogenized sample powder with 200 mg
of carefully dried and ground alkali halide. After grinding, the mixture is pressed
into a thin, transparent disk.
Both KCl and KBr work equally well. However, KCl is slightly less hygro-
scopic, and is generally recommended over KBr, especially when the analyte is
a hydrochloride salt (to eliminate the problem of halide exchange). Whether KBr
or KCl is used, it should be “IR grade” and dried at 110°C for a minimum of
one hour. It can be stored above a strong desiccant (e.g., phosphorus pentoxide)
in a desiccator, or left in the oven and removed on an “as needed” basis. This
may be important in any subsequent legal proceeding. Also, the material under
investigation can be recovered from the halide disc for further testing.
The Nujol mull method requires the mixing of a finely powdered sample
(2-3 mg) with one drop of nujol (liquid paraffin or perfluorinated long-chain
alkane), and then grinding the mixture in an agate mortar. The quantity of nujol
added is adjusted so that the final mull is the consistency of a thin cream. The
resulting mull is spread on an alkali halide disc (usually KBr) and a similar disc
placed on top. The film between the halide discs should contain no air bubbles.
The obvious disadvantage of this method is interference from the Nujol in the
spectrum. A similar approach, the thin film technique, is also used for the direct
analysis of ATS free bases, which are usually oily liquids.
Single reflection diamond ATR method (e.g. the ”Golden Gate” device) is a
relatively new method for both liquids and solids, which needs no sample prepa-
ration. However, spectra obtained with this method cannot be directly compared
with the ones obtained from any of the methods described above. Finally, the gas
cell method is a practical tool for quick analysis of solvents and some precursors
from clandestine laboratories.
Isolation of pure drug from sample
Isolation of the ATS free base
Dissolve 25-50 mg of the sample in 1 ml of 0.1N tartaric acid. Add 4-5 drops of
ammonium hydroxide and extract with chloroform. Pass the chloroform layer
through a small column containing a cotton plug to remove suspended particles.
*For solids it is important (a) to reduce the size of the particles by grinding to a dimension of
less than the shortest analytical wavelength (to avoid scattering), and (b) to dilute the sample in order
to minimize absorption in the prepared disk.
Allow a portion of the chloroform solution to evaporate directly onto a KBr disc
and record the infrared spectrum of the free base, for example, by the thin film
technique on KBr discs.
Isolation of the ATS salt
Triturate a 20-50 mg portion of the sample with 1-2 ml of chloroform. Filter,

collect the extract and concentrate by using a gentle stream of nitrogen. Induce
crystallization, filter, dry crystals, and run the infrared spectrum of the resulting
ATS salt by one of the methods described below.
Methods
Spectra of ATS salts are recorded using samples prepared by the following
methods:
앫 KBr halide disc (1-1.5%)
앫 Nujol mull methods
앫 Direct method, e.g. diffuse reflectance ATR
앫 Diffuse reflectance method
Spectra of ATS bases are recorded using samples prepared by the following
methods:
앫 Thin film method
앫 IR cards
앫 Direct method, e.g. diffuse reflectance ATR
Alternative IR sample preparation methods for methamphetamine
Serial dry extraction method

Place 200 mg of powdered methamphetamine sample into a disposable Pasteur
pipette with a glass wool plug at the end. Wash the sample with two 1 ml-por-
tions of acetone and collect the acetone fraction. After air-drying wash the
column with two 1 ml-portions of chloroform and collect the chloroform fraction.
Allow the column to dry again and then rinse with two 1 ml-aliquots of methanol
and collect the methanol fraction. The insoluble material can then be removed
from the pipette. All fractions are examined by infrared spectroscopy for
identification.
Physical separation/selective re-crystallisation

The procedures below work well for the type of mixtures indicated; they do not
work as well with amphetamine hydrochloride.
A mixture known to contain methamphetamine: Add in a beaker 25 mg of sam-

ple to 20 ml of a 2:1 mixture of chloroform and hexane, and concentrate the solu-
tion to approximately half the original volume. Add diethyl ether to precipitate
the methamphetamine. Filter, dry and obtain IR spectrum (methamphetamine
hydrochloride).
A mixture known to contain methamphetamine, pseudoephedrine, and ephedrine:

Place 100 mg of sample in a piece of filter paper and wash with 40 ml of a 3:1
mixture of chloroform and hexane. Wash the insoluble portion with chloroform,
and dry and recover for examination (ephedrine hydrochloride). Evaporate the
original solute to dryness and divide into two equal portions. Dissolve one half
of this sample in 20 ml of a 2:1 mixture of chloroform and hexane, concentrate
to approximately half the original volume, and add diethyl ether to precipitate the
methamphetamine. Filter, dry and obtain IR spectrum (methamphetamine
hydrochloride). Dissolve the other half of the sample in 2 ml of chloroform and
add 1.6 ml of hexane to precipitate the pseudoephedrine. Filter, dry and obtain
IR spectrum (pseudoephedrine hydrochloride).
Results
Identification is accomplished by comparing the spectrum of the analyte with that
of a reference standard, or from a spectral library.
Further reading
Alternative IR sample preparation methods for methamphetamine

Ely, R. A. (1993), Dry Serial Extraction of Illicit Methamphetamine Powders For the
Identification of Adulterants and Diluents By Infrared Spectroscopy, Journal of the
Clandestine Laboratory Investigating Chemists Association (JCLIC), vol. 3(1), pp. 21-25.
Oulton, S. R. (1997), Separation and Identification of Ephedrine, Pseudoephedrine and
Methamphetamine Mixtures, Microgram, vol. 30(12), pp. 289-296.
Stinson, S.B. and Berry, M.R. (1974), Separation and identification of amphetamine or
methamphetamine in combination with ephedrine or caffeine, vol. 7(4), p. 51.
General FTIR
Laboratory Methods in Vibrational Spectroscopy (third ed.) edited by Willis, H. A., van
der Maas J. H. and Miller, R. G. J., John Wiley & sons, Chichester, 1987
G. ANALYSIS OF OPTICAL ISOMERS
Most ATS have one asymmetric carbon atom resulting in a pair of enantiomers
for each ATS. Depending on the source, therefore, different enantiomeric forms
of amphetamine, methamphetamine or other ATS may be encountered in seized

samples submitted for analysis.
Under the 1971 UN Convention on Psychotropic Substances, each optical
isomer (d- and l-) as well as the racemic mixture (dl) of amphetamine and metham-
phetamine are scheduled. With most ring-substituted ATS, only the racemates are
listed, and individual enantiomers are included by means of a generic phrase.
Optical isomers differ to some extent in pharmacological activity and are
subject to different regulatory measures in certain countries. In countries where
national legislation requires that the specific optical isomer present be identified,
the following analytical procedures may be used.
1. MELTING POINT
Comparison of the melting point of the sample mixed with that of an enatio-
merically pure reference standard is a rapid and simple test to distinguish optical
isomers.
For example, d- and l-methamphetamine hydrochloride have the same melt-
ing point (170-175°C), but a mixture of equal amounts of both optical isomers
(racemic mixture) has a lower melting point (130-135°C).
This method requires fairly pure samples. Generally, melting points should
be determined using dried samples.
2. MICROCRYSTAL TESTS
(See also section on microcrystal test as a presumptive test, above)
For ATS, the “hanging drop” technique, or volatility test, is typically employed.
This technique requires a cavity slide, a cover glass, the testing reagent and a
volatilizing reagent. Preparation of testing and volatilization reagents is described
in annex III.
Microcrystal tests for optical isomers of amphetamine:
Gold chloride test [5% HAuCl4 in H3PO4]
Transfer a small quantity of the sample powder into the depression of the cavity
slide, and add one or two drops of the volatilizing reagent (5% NaOH solution).
This liberates the free amine in the form of a volatile free base, which rises from
the solution as a vapour. Immediately transfer a drop of the testing reagent (5%
HAuCl4 in H3PO4) onto a glass slide and invert the slide crosswise over the sam-
ple cavity. The reagent then reacts with the amine vapour present in the cavity.
After an appropriate interval, reinvert the reagent slide and examine for crystals
in the reagent or at the edge of the reagent drop.
Results
Both d- and l- amphetamine give identical microcrystals, resembling long yellow
rods or coarse needles and long narrow blades. The way to distinguish them is to
form the racemate, which does give different crystals. The dl-amphetamine
racemate gives at first “oily" drops then coloured platy crystals. These crystals
largely form after inversion.
Distinction of d- and l-amphetamine

If the above test indicates that the sample is d- or l-amphetamine, distinction should
be undertaken as to which is present. To this end, add some of the unknown
sample powder to a small amount of known d-amphetamine salt in one cavity and
to a small amount of l-amphetamine salt in another. Repeat the test above. The mix-
ture that is (d+d) or (l+l) will give the long yellow rods etc. The mixture that proves
to be (d+l) will give the platy crystals of the racemate as previously described.
Methamphetamine
d-Methamphetamine tested with 5% HAuCl4 in H3PO4 gives “V” blades with one
side shorter than the other side. These develop very rapidly if the test is done
directly on the dry sample, or more slowly if the sample is diluted or performed
using the hanging drop technique.
l-Methamphetamine gives single, crossed blades, and “v” blades, which form
characteristic cigar-shaped ends (they taper on both sides of the blade tip).
d,l-Methamphetamine forms single and “X” blades which are sometimes
“knife”-shaped. The blade ends only taper on one side similar to a knife.
MDMA
MDMA tested with 5% HAuCl4 in H3PO4 gives high birefringed white X-shaped crys-
tals with star-like clusters under polarized light. These crystals are similar to those of d,l-
methamphetamine with gold chloride, but can be differentiated with practice.
Note: Because MDMA is very sensitive in reacting with the gold chloride reagent,
only a very small portion is sufficient for good results.
The gold chloride test is also useful for the precursors ephedrine and pseudo-
ephedrine, and can be useful for nicotinamide and caffeine. Reference samples of
these substances should be used to obtain reference crystals.
Microcrystal tests for optical isomers of methamphetamine: [H3BiI6 in H2SO4]

Use hanging drop procedure as described above for amphetamine but using H3BiI6
in H2SO4 testing reagent (see annex III for preparation of the reagent).
Results
d-Methamphetamine gives long orange needles. dl-Methamphetamine gives

characteristic orange-red rods with slanting ends.
Further reading
Fulton, C. C. (1969). Modern Microcrystal Tests for Drugs, Wiley-Interscience, New York.
Ono, M., Microcrystal Test, Japan, 1996 (provides a comprehensive introduction to the
technique of microcrystal tests, and includes photographs of microcrystal test results of
39 ATS and their precursors).
Ruybal, R. (1986). Microcrystalline test for MDMA, Microgram, vol. 19 (6), pp. 79-80.
American Society of Analytical Chemistry: AOAC Official Methods of Analysis (1984),
pp. 704-714.
Stall, W. J. (1981). The separation of methamphetamine and procaine utilizing the volatil-
ity test/hanging drop method for amphetamines, Microgram, vol. 14 (10), p.148.
3. INSTRUMENTAL TECHNIQUES
There are a number of direct instrumental methods (chiral GC, HPLC or CE) and
indirect derivatization methods available for the analysis of optical isomers of
ATS. The choice of the method depends on the scope of the analysis, the avail-
ability of equipment and other laboratory requirements. Both direct and indirect
methods should be considered as complementary since neither offers a universal
solution for chiral separation. The strengths and weaknesses of both approaches
should be considered with care.
Direct instrumental methods allow the analysis of optical isomers without
derivatization, using chiral stationary phases and/or chiral additives to the run
buffer (CE).
Indirect methods are based on the derivatization of the analyte with a chiral
reagent to produce two different diastereoisomers with different physico-chemi-
cal properties that can be separated on an achiral stationary phase. The choice of
the chiral reagent depends on number of factors such as separation power, sensi-
tivity, efficiency of derivatization, and its compatibility with the instrumental tech-
nique. Methods using chiral derivatization are essentially less expensive and do
not require specialized equipment or columns. The use of normal, achiral columns
allows easy integration of chiral separations into routine analysis schemes.
GC techniques
Gas chromatography (GC) is a well established technique for chiral separation. It

can be performed using direct methods, employing chiral capillary columns, or
indirect methods, where separation is achieved by using chiral reagents and achi-
ral stationary phases.
Chiral gas chromatography (direct GC method)
Commercially available stationary phases for the GC separation of optical isomers

are usually produced by addition of derivatized cyclodextrin macromolecules to
a common stationary phase. The most commonly used chiral stationary phase for
ATS is beta-cyclodextrin based.
Method
Sample preparation (extraction) for chiral GC analysis is the same as for normal
GC (see above).
Column: Dexcst, 0.25 mm x 30 m x 0.25 micron film, or
equivalent
Carrier gas: Helium at approx. 1.2 ml/min
Oven temperature: 120°C for 1 min., then 1.5°C/min to 175°C, hold for
1.5 min.
Injection volume: 1 애l
Injector temperature: 190°C
Detector temperature: 280°C
Note: Other GC operating conditions can be used, but need to be tested for optimal separation of chi-
ral compounds. Use of nitrogen as carrier gas requires lower flow rates (approx. 0.8 ml/min.) for opti-
mal velocity, resulting in broader peaks.
Chiral derivatization (indirect GC method)
Diastereoisomers of ATS can be prepared using different reagents such as

acylchlorides, alkylsulphonates, isothiocyanates, chloroformates. Mosher’s acid
[R(+)- or S(-)-움-methoxy-움-(trifluoromethyl)-phenylacetic acid], Mosher’s acid
chloride, and N-trifluoroacetyl-1-prolyl chloride (TPC, also known as TFAP-Cl)
are the most popular.
Mosher’s acid and acid chloride results in quantitative derivatization of most
amines, with the exception of ephedrine and pseudoephedrine. It can be used as
reagents for both GC and HPLC analysis.
TPC is known to produce stable derivatives of almost all ATS including
ephedrines. It is more amenable for GC analysis.
Details of ATS sample preparation using Mosher’s acid and TPC for chiral
derivatizations are described in annex VII.
The GC operating conditions for qualitative GC analysis (see above) can also
be used for the analysis of chiral derivatives.
Further reading
Beckett, A. H. and Testa, B. (1972). Stereochemical separation and configural assign-
ment by gas-liquid chromatography of N-trifluoroacetyl-l-prolyl amides of asymmetric
l-phenylisopropyl-amines, J. Chromatogr., vol. 69, pp. 285.
Cody, J. T., (1992). Determination of methamphetamine enantiomer ratios in urine by gas
chromatography-mass spectrometry, J. Chromatogr., vol. 580, pp. 77-95.
Jirovský, D., et al. (1998). Methamphetamine—properties and analytical methods of
enantiomer determination, Forensic Sci. Int., vol. 96, pp. 61-70.
Liu, J. H. and Ku, W. W. (1981). Determination of enantiomeric N-trifluoroacetyl-l-prolyl
chloride amphetamine derivatives by capillary gas chromatography/mass spectrometry with
chiral and achiral stationary phases, Anal. Chem., vol. 53, pp. 2180.
Liu, J. H., Ku, W. W., Tsay, J. T., Fitzgerald, M. P., and Kim, S. (1982). Approaches to
drug sample differentiation. III: A comparative study of the use of chiral and achiral
capillary column gas chromatography/mass spectrometry for the determination of metham-
phetamine enantiomers and possible impurities, J. Forensic Sci., vol. 27 (1), pp. 39-48.
Liu, J. H., Ku, W. W. and Fitzgerald, M. P. (1983). Separation and characterization of
amine drugs and their enantiomers by capillary column gas chromatography—mass spectro-
metry, J. Assoc. of Anal. Chem., vol. 66, pp. 1443.
McKibben, T. (1992). Separation and Identification of Drug Enantiomers via N TFA (S)
Prolyl Chloride Derivatization, Journal of the Clandestine Laboratory Investigating
Chemists Association, vol. 2 (1), pp. 21 20. (This reference includes derivatization of both
enantiomers of amphetamine, methamphetamine, ephedrine, pseudoephedrine, MDA,
MDMA, DOB, DOM, 2,4,6 TMA, 3,4,5 TMA, propylhexedrine, and PMA.)
R. Kaslauskas, G. Trouth and A. Lissi (AGAL), 16 Cologne workshop on doping
analysis: Moshers acid,
Pastor-Navarro, M. D., Porras-Serrano, R., Herraez-Hernandez, R., Campins-Falco, P.
(1998). Automated determination of amphetamine enantiomers using a two-dimensional
column-switching chromatographic system for derivatization and separation, Analyst,
vol. 123, pp. 319.
Shin, H. S. and Donike, M. (1996). Stereospecific derivatization of amphetamines, phenol
alkylamines, and hydroxyamines and quantification of the enantiomers by capillary
GLC/MS, Anal. Chem., vol. 68, pp. 3015.
Wells, C. E. (1970). GLC determination of the optical isomers of amphetamine, J. Assoc.
of Anal. Chem., vol. 53, pp. 113.
HPLC techniques
For HPLC, various approaches have been used, including derivatization with chi-
ral reagents, incorporation of chiral additives in the mobile phase, and the use of
chiral stationary phases. A variety of chiral HPLC columns are commercially avail-
able. The performance of chiral stationary phases in HPLC has been dramatically
improved in recent years, although such analyses are still expensive.
Further reading
Lemr, K., Jirovsky, D. and Seveik, D. (1996). Effect of Some Parameters on Enantiomer
Separation of Ephedrine, Methamphetamine and Selegiline using HPLC with 웁-Cyclo-
dextrin Stationary Phase, J. Liq. Chrom. & Rel. Technol., vol. 19, pp. 3173-3191.
Makino, Y., Suzuki, A., Shirota, T. Ogawa, Shirota, O. (1999). Direct analysis of metham-
phetamine enantiomers in urine with strong cation exchange pre-column and 웁-cyclo-
dextrin-bonded semi-micro column, J. Chromatography B, vol. 729, pp. 97-101.
Noggle, F. T., DeRuiter, J. and Clark, C. R. (1986). Liquid Chromatographic Determination
of the Enantiomeric Composition of Methamphetamine Prepared from Ephedrine and
Pseudoephedrine, Anal. Chem., vol. 58, pp 1643-1648
Pihlainen, K. and Kostiainen, R. (2004). Effect of the Eluent on Enantiomer Separation of
Controlled Drugs by Liquid Chromatography-Ultraviolet Absorbance Detection-Electro-
spray Ionisation Tandem Mass Spectrometry using Vancomycin and Native 웁-Cyclodextrin
Chiral Stationary Phases, J. Chromatogr. A., vol. 1033, pp. 91-99.
Rizzi, A. M., Hirz, R., Cladrowa-Runge, S. and Jonsson, H. (1994). Enantiomeric Separation
of Amphetamine, Methamphetamine and Ring Substituted Amphetamines by Means of a 웁-
Cyclodextrin-Chiral Stationary Phase, Chromatographia, vol. 39, pp. 131-137.
Sadeghipour, F. and Veuthey, J. L. (1998). Enantiomeric Separation of Four Methylene-
dioxylated Amphetamines on 웁-Cyclodextrin Chiral Stationary Phases, Chromato-
graphia, vol. 47, pp. 285-290.
Sellers, J. K., Duffitt, G. L., Gaines, M. L. and Liu, R. H. (1996). High Performance Liquid
Chromatographic Analysis of Enantiomeric Composition of Abused Drugs, Forensic Sci.
Rev., vol. 8, pp. 92-108.
CE techniques
Capillary zone electrophoresis is highly advantageous for chiral analysis since it

allows for the highly efficient separation of enantiomers without derivatization
and specialty columns (capillaries). For the separation of ATS, chiral additives to
the run buffer such as hydroxyl-propyl beta-cyclodextrin are commonly used.
Further reading
Iwata, Y. T., Garcia, A, Kanamori, T., Inoue, H., Kishi. T. and Lurie, I.S. (2002). The Use
of Highly Sulfated Cyclodextrin for the Simultaneous Chiral Separation of Amphetamine-
type Stimulants by Capillary Electrophoreis, Electrophoreis., vol. 23, pp. 1328-1334.
Lurie, I. S., Hays, P. A. and Parker, K. P. (2004). Capillary Electrophoreis Analysis of a
Wide Variety of Seized Drugs Using the Same Capillary with Dynamic Coatings,
Electrophoresis., vol. 25, pp. 1580-1591.
Lurie, I. S., Klein, R. F. K., Dal Cason, T., LeBelle, M., Brenneisen and R., Weinberger, R.
(1994). Chiral Resolution of Cationic Drugs of Forensic Interest by Capillary Electro-
phoresis with Mixtures of Neutral and Anionic Cyclodextrins, Anal. Chem., vol. 66, pp.
4019-4026.
Varesio, E., Gauvrit, J. Y., Longeray, R., Lanteri, P., Veuthey, J. L. (1997). Central
Composite Design in the Chiral Analysis of Amphetamines by Capillary Electrophoresis,
Infrared (IR) techniques
Although enantiomers have the same infrared spectrum, infrared (IR) spectroscopy
can be used to distinguish between enantiomers of a given compound after con-
verting them into the corresponding diastereomers.
ATS, as all organic bases can easily be reacted with chiral organic acids
to form diastereomers. D- and l-amphetamine, for instance, can be coupled with
d-mandelic acid to form two diastereomers, d-amphetamine-d-mandelate and
l-amphetamine-d-mandelate, which have different IR spectra.
Method
An aqueous solution of ATS salt (10-50 mg) is made alkaline, and the ATS
extracted into methylene chloride. The methylene chloride is dried over anhydrous
sodium sulphate and concentrated to approximately 2 ml. A saturated solution of
d-mandelic acid in methylene chloride is added, several drops at a time, until the
ATS solution is neutralized (pH paper). The d-mandelate-ATS salt is allowed to
crystallize, the solution filtered through suction, and the crystals are washed with
a small portion of methylene chloride. After drying, a KBr disc of the crystals is
prepared, and the infrared spectrum acquired. The procedure is repeated using
known optically pure isomers of corresponding ATS.
Results
Identification of optical isomers is accomplished by comparing the resulting spec-

tra with those obtained from appropriate pure reference standards. IR bands in the
800-1600cm–1 region provide the most analytically distinctive information.
IR spectra of the salts of optical isomers of amphetamine with mandelic acid
are given in the earlier edition of the UN manual “Recommended methods for
testing amphetamine and methamphetamine” (ST/NAR/9). Data can also be
accessed at the Laboratory and Scientific Section’s web page.
Further reading
Chappell, J. S. (1997). Infrared discrimination of enantiomerically enriched and racemic
samples of methamphetamine salts, Analyst, vol. 122, pp. 755-760.
Chappell, J. S. (1998). A novel infrared method for the determination of the enantiomeric
composition of methamphetamine salts, Proceedings of the American Academy of Forensic
Sciences, vol. 4, p. 32.
Heagy, J. (1970). Infrared method for distinguishing optical isomers of amphetamine,
Analytical Chemistry, vol. 42, pp. 1459.
VII. ADDITIONAL ANALYTICAL
TECHNIQUES FOR THE
ANALYSIS OF ATS
There are a number of additional analytical techniques suitable for the forensic
identification and/or quantitation of ATS, such as:
앫 Capillary electrophoresis (CE)
앫 Gas chromatography-Fourier transformed infrared spectroscopy (GC-FTIR)
앫 LC-MS and CE-MS
앫 Near Infrared (NIR) Spectroscopy
앫 Nuclear magnetic resonance (NMR) spectroscopy (qualitative and
quantitative)
앫 Quantitative FTIR
앫 Quantitative TLC
앫 Raman FTIR spectroscopy
앫 Solid phase-micro extraction-gas chromatography (SPME-GC)
A description of most of these techniques is beyond the scope of this “Manual
on recommended analytical methods for ATS”, and the analyst is referred to a
complementary “Manual on analytical techniques generally, their characteristics
and practical use for drug analysis”. Four techniques, qualitative NMR, CE,
SPME-GC, and GC-FTIR are briefly described below, because they offer specific,
attractive options for the analysis of ATS.
1
A. H-NUCLEAR MAGNETIC RESONANCE (NMR) TECHNIQUES
The availability of a large number of positional isomers of structurally related

ATS, especially ring-substituted ATS, requires effective tools that provide the nec-
essary structural information for their differentiation. NMR enables the analyst to
unequivocally distinguish between different ring-substituted amphetamine deriva-
tives, even in the presence of diluents and other adulterants. Although certain sub-
stitution patterns resemble one another in the area corresponding to the protons
of the alkyl side chain, the integrated spectrum and the pattern of the aromatic
proton signals allow their distinction from one another. While being a powerful
tool for the identification of analogues, the cost of NMR spectroscopy and the
technical expertise required prevent its widespread application in routine analysis.
51
Method
Dissolve about 20 mg of the drug sample in 1 ml of D2O. If insoluble materials

are present, centrifuge, otherwise transfer directly the supernatant into an NMR
tube. Record the spectrum of this solution containing the salt form of the ATS.
Liberate the free base of the ATS in situ by the addition of 20-30 mg of
solid K2CO3 and 0.5 ml of CDCl3 and record the spectrum of the free base.
Compare the spectrum of the unknown with the reference spectra, which were
recorded on a Fourier transform instrument at 90 MHz using a flip angle of 18°
(1 애sec) with no delay following data acquisition.
Reference NMR spectra of selected ATS are given in the earlier edition of
the two UN manuals related to the analysis of ATS, namely, “Recommended
methods for testing amphetamine and methamphetamine” (ST/NAR/9) and
“Recommended methods for testing illicit ring-substituted amphetamine deriva-
tives” (ST/NAR/12). Data can also be accessed at the Laboratory and Scientific
Section’s web page.
Further reading
Dawson, B. A. (1991). The use of Nuclear Magnetic Resonance Spectroscopy for the detec-
tion and quantitation of abused drugs, in: The analysis of drugs of abuse, T. A. Gough
(ed.), Wiley & Sons Ltd, pp. 284-296.
Lee G. S. H, Craig D. C., Kannangar G. S. K., Dawson, M., Conn C., Robertson J.,
Wilson M. A. (1999). Analysis of 3,4-methylenedioxy-N-methylamphetamine (MDMA) in
"ecstasy" tablets by 13C solid state nuclear magnetic resonance (NMR) spectroscopy,
J. Forensic Sci., vol. 44 (4), pp. 761-771.
Chew, S. L., and Meyers, J. A. (2003). Identification and quantitation of gamma-hydroxy-
butyrate (NaGHB) by nuclear magnetic resonance spectroscopy, J. Forensic Sci., vol. 48
(2), p. 292.
Rothchild, R. (2003). Identification of heroin diluent: one- and two-dimensional proton and
carbon-13 NMR studies of procaine hydrochloride: computational studies of procaine and
its conjugate acid, Spectroscopy Letters, vol. 36 (1&2), pp. 35-42.
B. CAPILLARY ELECTROPHORESIS (CE)
CE, similar to HPLC, requires no derivatization or extraction steps, and therefore

is advantageous over GC for the analysis of ATS compounds. In contrast to HPLC,
CE offers higher resolving power for the analysis of these solutes, which trans-
lates into faster analysis. The use of dynamically coated capillaries provides for
significant improvement in precision, peak efficiency and/or separation times for
ATS compounds over comparable methods using uncoated capillaries. In addition
the dynamically coated capillary approach can allow for the rapid chiral analysis
Additional analytical techniques for the analysis of ATS 53
of a sample using the same capillary and sample vial but a different run buffer.
See annex VI for validated CE method for quantitation of selected ATS and for
methodology to differentiate optical isomers.
Further reading
Lurie, I. S., Hays, P. A. and Parker, K. P. (2004). Capillary Electrophoreis Analysis of a
Lurie, I. S., Bethea, M .J., McKibben, T.D., Hays, P. A., Pellegrini, P., Sahai, R.,
Garcia, A. G. and Weinberger R. (2001). Use of Dynamically Coated Capillaries for the
Routine Analysis of Methamphetamine, Amphetamine, MDA, MDMA, MDEA and Cocaine
using Capillary Electrophoresis, J. Forensic Sci., vol. 46, pp. 1025-1032.
Piette, V. and Parmentier, F. (2002). Analysis of Illicit Amphetamine Seizures by Capillary
Zone Electrophoreis, J. Chromatogr. A., vol. 979, pp. 345-352.
C. SOLID PHASE-MICRO EXTRACTION-GAS CHROMATOGRAPHY

(SPME-GC)
SPME (solid phase micro extraction) is a solvent free sample preparation tech-
nique, which can be used for headspace analysis over solutions, or directly over
ATS powders, or it can be used for (trace) analysis of aqueous solutions contain-
ing ATS. SPME is typically performed with a special syringe fitted with a silica
fibre placed on top of the syringe piston. The fibre is coated with a polymeric
phase like the ones used in capillary columns. During sampling, the coating fibre
absorbs the compounds from the gas phase in the headspace, or directly from the
aqueous phase. Many different fibre coatings are available for analysis of ATS
and other substances. One of the most used is, for example, a polydimethylsiloxane
(PDMS) coated fibre.
Headspace method
An aqueous ATS sample is made alkaline to convert the amines into free bases,
thus increasing their volatility. The sample can additionally be heated in order to
increase the amount of amines in the gas phase above the sample solution. The
syringe with the exposed fibre is placed in the headspace above the solution and
the ATS free bases are absorbed on the fibre. At the equilibrium, the extracted
amount of every compound absorbed on the fibre is proportional to their concentra-
tion in the solution, though with different distribution coefficients. After the extrac-
tion is completed, the syringe is transferred to the chosen analytical instrument.
When the fibre is inserted into the heated GC injector port, the extracted amines
are thermally desorbed. In HPLC, CEC and CE, the solvent mixture elutes the
amines form the fibre.
(Trace) analysis from aqueous samples
The fibre is dipped directly into the aqueous sample solution, which was made
alkaline in order to release the ATS free bases. The sample solution is stirred to
increase the exchange of the compounds between the solution and the fibre for a
speedier extraction. Sample analysis is carried out in the same way as described
in the headspace method.
Further reading
Battu, C., Marquet, P., Fauconnet, A. L., Lacassie, E. and Lachâtre, G. (1998). Screening
procedure for 21 amphetamine-related compounds in urine using solid-phase microextraction
and gas chromatography-mass spectrometry, J. Chromatogr. Sci., vol. 36, pp. 1-7.
Centini, F., Masti, A. and Barni Comparini, I. (1996). Quantitative and Qualitative analy-
sis of MDMA, MDEA, MA and amphetamine in urine by head-space/solid phase micro-
extraction (SPME) and GC-MS, Forensic Science International, vol. 83, pp. 161-166.
Pawliszyn, J., Solid Phase Microextraction, Wiley-VCH, New York, 1997.
Yashiki, M., Kojima, T., Miyazaki, T., Nagasawa, N., Iwasaki, Y. and Hara, K. (1995).
Detection of amphetamines in urine using head space-solid phase microextraction and
chemical ionization selected ion monitoring, Forensic Science International, vol. 76,
pp. 169-177.
Zhang, Z., Yang, M. J. and Pawliszyn, J. (1994). Solid-Phase Microextraction, Analytical
Chemistry, vol. 66, No. 17, pp. 844A-855A.
D. GAS CHROMATOGRAPHY-FOURIER TRANSFORM

INFRARED SPECTROSCOPY (GC-FTIR)
GC-FTIR, as another hyphenated technique, unifies the advantages of a the GC

separation technique with the high analyte specificity of IR. GC-FTIR with a light
pipe flow cell has no limitations as to the carrier gas flow, which makes it ideal
for use with short wide bore columns, thus resulting in efficient and fast analy-
sis. For instance, most common ATS can be analyzed within less than five min-
utes. However, since the technique is rather insensitive, large amounts of substance
have to be injected, and the film thickness of the stationary phase is critical in
order not to overload the column.
Additional analytical techniques for the analysis of ATS 55
Method
ATS sample preparation
Sample preparation is the same as for qualitative GC analysis above, but the tar-
get analyte concentrations should be 1-10 mg/ml.
General GC conditions shown above (e.g., GC-FID or GC-MS method) can be
used, with the following modifications:
GC column: Wide bore column 0.32-0.53 mm ID

Column length: 3-10 m
Film thickness: 욷 1.0 애m
Temperature of transfer line: 300°C
Spectral resolution: 8 cm–1
Results
Identification is accomplished by comparing the retention time and FTIR spec-

trum of the analyte with that of a reference standard.
Further reading
Bergkvist, H., Eyem. J. and Lundberg, L. in: Sandra, P. (Ed), Proceedings of the Thirteenth
International Symposium of Capillary Chromatography, Riva del Garda, May 13-16, 1991,
Huertig, Heidelberg, pp. 1160-1170.
Duncan, W. and Soine, W.H., Identification of Amphetamine Isomers by GC/IR/MS, J.
Chromatogr. Sci., vol. 26, 1988, pp. 521-526.
Griffiths, P. R. and de Haseth, J. A., Fourier Transform Infrared Spectrometry, John Wiley
& Sons, New York, 1986.
Annex I. Chemical structures of selected ATS
Table A1. Non-ring substituted amphetamines
R4 R1
N
R2
R3
Note: Unless indicated specifically, names do not refer to individual enantiomers
Common name IUPAC name R1 R2 R3 R4
Amphetamine 1-methyl-2-phenylethylamine H H CH3 H

Methamphetamine N-methyl-N-
(1-methyl-2-phenylethyl)amine CH3 H CH3 H
N-Ethylamphetamine N-ethyl-N-
(1-methyl-2-phenylethyl)amine C2H5 H CH3 H
Dimethylamphetamine N,N-dimethyl-N-
(1-methyl-2-phenylethyl)amine CH3 CH3 CH3 H
N-Hydroxyamphetamine N-(1-methyl-2-phenylethyl)
hydroxylamine H OH CH3 H
N-Hydroxymethamphetamine N-methyl-N-
(1-methyl-2-phenylethyl)
hydroxylamine CH3 OH CH3 H
Cathine (1S,2S)-2-amino-1-phenylpropan-
1-ol H H CH3 OH
Cathinone 2-amino-1-phenylpropan-1-one H H CH3 =O
Methcathinone 2-(methylamino)-1-phenylpropan-
1-one CH3 H CH3 =O
Fenetylline 1,3-dimethyl-7-{2-
[(1-methyl-2-phenylethyl)amino]
ethyl}-3,7-dihydro-1H-purine-
2,6-dione H theo- CH3 H
phylline
Phenylpropylmethylamine N-methyl-N-(2-phenylpropyl)amine CH3 H CH3 CH3
(PPMA)
57
Table A2. Methylenedioxy substituted amphetamines
R1
N
O
R2
R3
O
R6
Common name IUPAC name R1 R2 R3 R4
3,4-methylenedioxy-
amphetamine 1-(1,3-benzodioxol-5-yl)
(MDA, tenamfetamine) propan-2-amine H H CH3 H
3,4-methylenedioxy- N-[2-(1,3-benzodioxol-5-yl)-
methamphetamine (MDMA) 1-methylethyl]-N-methylamine CH3 H CH3 H
3,4-methylenedioxy-
ethylamphetamine N-[2-(1,3-benzodioxol-5-yl)-1-
(MDE, MDEA) methylethyl]-N-ethylamine C2H5 H CH3 H
3,4-methylenedioxy-N,N-
dimethylamphetamine N-[2-(1,3-benzodioxol-5-yl)-1-
(MDDM) methylethyl]-N,N-dimethylamine CH3 CH3 CH3 H
N-hydroxy-3,4-methylene-
dioxyamphetamine
(N-hydroxy-MDA, N-[2-(1,3-benzodioxol-5-yl)-1-
N-hydroxytenamfetamine) methylethyl]hydroxylamine H OH CH3 H
N-hydroxy-N-methyl-3,4- N-[2-(1,3-benzodioxol-5-yl)-1-
methylenedioxyamphetamine methylethyl]-N-
(N-hydroxy-MDMA, FLEA) methylhydroxylamine CH3 OH CH3 H
N-methyl-1-
(3,4-methylenedioxyphenyl)- N-[1-(1,3-benzodioxol-5-ylmethyl)
2-butanamine (MBDB) propyl]-N-methylamine CH3 H C2H5 H
1-(3,4-methylenedioxyphenyl)- 1-(1,3-benzodioxol-5-yl)
2-butanamine (BDB) butan-2-amine H H C2H5 H
5-methoxy-3,4-
methylenedioxyamphetamine 1-(7-methoxy-1,3-benzodioxol-5-yl)
(MMDA) propan-2-amine H H CH3 OCH3
Annex I. Chemical structures of selected ATS 59
Table A3. Other ring substituted amphetamines
R1
R8 NH
R3
R7 R5
R6
Common name IUPAC name R1 R3 R5 R6 R7 R8
2,4,5-Ring substituted phenethylamines

4-Bromo-2,5-dimethoxy- 2-(4-bromo-2,5-dimethoxy-
phenetylamine (2C-B, Nexus) phenyl)ethanamine H H OCH3 H Br OCH3
4-Methylthio-2,5-dimethoxy- 2-[2,5-dimethoxy-4-(methyl-
phenethylamine (2C-T) thio)phenyl]ethanamine H H OCH3 H SCH3 OCH3
4-Ethylthio-2,5-dimethoxy- 2-[4-(ethylthio)-2,5-di-
phenethylamine (2C-T-2) methoxyphenyl]ethanamine H H OCH3 H SC2H5 OCH3
4-Propylthio-2,5-dimethoxy- 2-[2,5-dimethoxy-4-(propyl-
phenethylamine (2C-T-7) thio)phenyl]ethanamine H H OCH3 H SC3H7 OCH3
4-Chloro-2,5-dimethoxy- 2-(4-chloro-2,5-dimethoxy-
phenethylamine (2C-C) phenyl)ethanamine H H OCH3 H Cl OCH3
4-Iodo-2,5-dimethoxy- 2-(4-iodo-2,5-dimethoxy-
phenethylamine (2C-I) phenyl)ethanamine H H OCH3 H I OCH3
2,4,5-Ring substituted amphetamines
2,4,5-Trimethoxyamphetamine 1-(2,4,5-trimethoxyphenyl)
(TMA-2) propan-2-amine H CH3 OCH3 H OCH3 OCH3
4-Methyl-2,5-dimethoxy- 1-(2,5-dimethoxy-4-
amphetamine (DOM, STP) methylphenyl)propan-2-amine H CH3 OCH3 H CH3 OCH3
4-Bromo-2,5-dimethoxy- 1-(4-bromo-2,5-dimethoxy-
amphetamine phenyl)propan-2-amine
(DOB, Bromo-STP, BDMA) H CH3 OCH3 H Br OCH3
4-Chloro-2,5-dimethoxy- 1-(4-chloro-2,5-dimethoxy-
amphetamine (DOC) phenyl)propan-2-amine H CH3 OCH3 H Cl OCH3
4-Iodo-2,5-dimethoxy- 1-(4-iodo-2,5-dimethoxy-
amphetamine (DOI) phenyl)propan-2-amine H CH3 OCH3 H I OCH3
4-Ethyl-2,5-dimethoxy- 1-(4-ethyl-2,5-dimethoxy-
amphetamine (DOET) phenyl)propan-2-amine H CH3 OCH3 H C2H5 OCH3
Other ring substitution patterns (phenethylamines and amphetamines)
3,4,5-Trimethoxyphenethyl- 2-(3,4,5-trimethoxyphenyl)
amine (mescaline) ethanamine H H H OCH3 OCH3 OCH3
para-Methoxyamphetamine 3-(4-methoxyphenyl)-
(PMA) 1-methylpropylamine H CH3 H H OCH3 H
para-Methoxy- N-[2-(4-methoxyphenyl)-1-
methamphetamine (PMMA) methylethyl]-N-methylamine CH3 CH3 H H OCH3 H
2,5-Dimethoxyamphetamine 1-(2,5-dimethoxyphenyl)
(DMA) propan-2-amine H CH3 OCH3 H H OCH3
3,4,5-Trimethoxyamphetamine 1-(3,4,5-trimethoxyphenyl)
(TMA) propan-2-amine H CH3 H OCH3 OCH3 OCH3
4-Methylthioamphetamine 1-[4-(methylthio)phenyl]
(4-MTA) propan-2-amine H CH3 H H SCH3 H
Annex II. Preparation of colour and
anion test reagents
All reagents should be prepared according to an established procedure.
Chen's test
Reagent 1: Add 1 ml of glacial acetic acid to 100 ml of water (=1% (v/v) aqueous
acetic acid solution)
Reagent 2: Dissolve 1 g of copper(II) sulphate in 100 ml of water (=1% (w/v)
aqueous CuSO4 solution)
Reagent 3: Dissolve 8 g of sodium hydroxide in 100 ml of water (=2N aqueous
sodium hydroxide solution).
Gallic acid test

Reagent: Dissolve 0.1 g of gallic acid in 20 ml of concentrated sulphuric acid
(=0.5% (w/v) solution)
Marquis test
Reagent 1: Add 8-10 drops (approx. 0.25 ml) of 37% formaldehyde solution to 10
ml of glacial acetic acid
Reagent 2: Concentrated sulphuric acid
Phosphate test
Ammonium molybdate: Dissolve 10 g of ammonium molybdate [(NH4)6Mo7O24 x
4H2O] in 100 ml of water (=10% (w/v) aqueous ammonium
molybdate solution)
Nitric acid: Carefully add 10 ml of nitric acid to 90 ml water (= 10% (v/v) nitric
acid solution)
Silver nitrate test (also known as Chloride test)

Dissolve 1.7 g of silver nitrate in 100ml of water (=1.7% aqueous silver nitrate
solution).
Simon’s test
Reagent 1: Dissolve 2 g of sodium carbonate in 100 ml of water (=2% aqueous
sodium carbonate solution)
Reagent 2: Dissolve 0.9 g of sodium nitroprusside in 90 ml of water (=1% aqueous
sodium nitroprusside solution)
Reagent 3: Mix 10 ml of acetaldehyde solution and 10 ml of ethanol (=50% (v/v)
ethanolic acetaldehyde solution)
61
Sulphate test
Dissolve 5 g of barium chloride dihydrate in 100 ml of water (= approx. 5% aqueous
barium chloride solution).
There are other established procedures for the preparation of colour test reagents, for
example, Clarke’s, which show slight variation in recipes.
Annex III. Microcrystal tests
Classified typical microcrystals
Typical forms of microcrystal can be classified into nine groups, using the descriptive terms
below. In order to allow description of all types of microcrystals, adjectives such as
irregular, fine, or square-cut should be added to the basic terms.
Source: Ono, M., Microcrystal Test, Japan, 1996
Reagents
Testing reagent—5% HAuCl4 in H3PO4
Dissolve 1 g of commercial gold trichloride acid (HAuCl4 x 4H2O) in 20 ml of a solution
containing one volume of concentrated H3PO4 and two volumes of water.
63
Testing reagent—H3BiI6 in H2SO4

Dissolve 1.25 g potassium iodide in 2.0 ml of water. Add 2.5 ml of a solution of H2SO4
diluted 1:7 with water, 0.5 ml of concentrated Bi(NO3)3 solution and 0.1 g of sodium
hypophosphite. The concentrated Bi(NO3)3 stock solution is prepared by dissolving 50 g
of bismuth subnitrate in 70 ml of a solution of HNO3 (diluted 1:1 with water) and made
up to 100 ml with water. The testing reagent can be kept for several months.
Volatilising reagent
Prepare a 5% aqueous NaOH solution.
Annex IV. Validated GC methods for
quantitation of selected ATS
Examples of validated GC methods for the quantitative analysis of selected ATS are pro-
vided below. Method B does not require derivatization, while method C requires silylation.
The described ATS standard and samples solutions and their concentrations are designed
for use with capillary columns and the procedures described below. The use of alternative
columns and GC systems may necessitate changes in terms of both relative composition
and concentrations of individual components.
Equipment and reagents
앫 Grade B volumetric glassware or better.

앫 Gas Chromatograph fitted with flame ionisation detector
앫 Analytical balance capable of weighing to an accuracy of ± 0.0001 g.
앫 All reagents must be of analytical reagent grade.
Method B: Multiple-point calibration method without derivatization
Method B is a validated method for the quantitative GC analysis of underivatized ATS,

specifically the following: amphetamine, methamphetamine, MDA, MDMA, MDEA and
MBDB.
Preparation of internal standard solution (IS): Phenylbenzylamine (PBA)

Accurately weigh 0.3 to 0.4 g of PBA into a 500 ml volumetric flask and dilute to
volume with chloroform to give an internal standard solution of 0.6 to 0.8 mg/ml.

Standard stock solutions should contain all compounds of interest in concentrations of
approximately 1000 mg/l. They may be kept in a closed flask in a refrigerator for up to
one year. For the preparation of stock solutions:
(a) Accurately weigh approximately 1000 mg of the compound(s) of interest into a
1000 ml volumetric flask and make to the mark with water.
(b) Accurately pipette 5 ml of this solution into a 20 ml glass stoppered test tube. Basify
to litmus by adding a few drops of concentrated ammonia solution. Accurately add
5 ml of chloroform.
(c) Stopper and shake well, then let stand until the layers separate. Using a Pasteur pipette,
transfer approximately 1 ml of the chloroform layer through anhydrous sodium sulphate
65
into a small beaker. This standard solution must not be left to stand more than half
an hour before used for calibration.
(d) For the preparation of calibration standards for a 5-point calibration, prepare the
different levels as follows:
Preparation of 5-point calibration standards
Calibration ATS standard IS solution Approx. concentration

level solution (애l) (애l) CHCl3 (애l) of ATS-salt (mg/l)
Level 1 20 100 880 20

Level 2 40 100 860 40
Level 3 60 100 840 60
Level 4 80 100 820 80
Level 5 100 100 800 100
Preparation of ATS sample solutions (unknown ATS sample)

In general, but specifically for quantitative analyses, homogenize samples before starting
any tests or sub-sampling.
(a) Accurately weigh a sufficient sample quantity into a 25 ml volumetric flask to obtain
a final concentration of approximately 0.2-1 mg/ml of analyte. Make to the mark with
water. (Note: The amount of the sample to be weighed will depend on the anticipated
purity as indicated by the preliminary screening method. As an example, if the
anticipated purity is about 40%, the sample amount used should be approx. 60 mg.)
5 ml of chloroform.
transfer approximately 1 ml of this sample solution through anhydrous sodium
sulphate into a small beaker. Measure 100 애l of sample solution, 100 애l of internal
standard solution and 800 애l of chloroform into GC sample vial.
(d) Inject into the gas chromatograph.
For quantitative analyses, a GC equipped with an autosampler is preferable. It is
acknowledged that use of different instruments may require adjustments in the operating
conditions.
Column: HP-5, 0.32 mm x 30 m x 0.5 애m
Carrier gas: Helium at approx. 1.2 ml/min (head pressure 12 psi)
Oven temperature: 100°C for 4 min, then 10°C/min to 270°C, and hold for
1 minute
Detector: Flame ionisation detector at 270°C
Annex IV. Validated GC methods for quantitation of selected ATS 67
Approximate retention times
Amphetamine 7.18 min.

Methamphetamine 8.25 min.
MDA 13.16 min.
MDMA 13.93 min.
MDEA 14.58 min.
MBDB 15.17 min.
Phenylbenzylamine (IS) 16.33 min.
Caffeine 17.92 min.
Ketamine 18.33 min.
Calculations
For routine analysis, the computer software will perform the calculations upon completion
of the analytical run. The result will be automatically printed on a report and expressed as
%w/w of an analyte as a base (i.e., weight of analyte, relative to sample weight).
Method C: Calibration method using BSTFA as a derivatization reagent

(single- or multiple-point calibration)
Method C is a validated method for the quantitative GC analysis of derivatized ATS, speci-
fically the following: ephedrine, pseudoephedrine, BDMA (4-bromo-2,5-dimethoxy-
amphetamine) and 2C-B
Use of method C is specifically recommended for ATS samples that contain ephedrine
and/or pseudoephedrine, which are frequently not resolved from other analytes and pro-
duce broad peaks. For further details on derivatization see annex VII.
Preparation of internal standard solution (IS): Phenylbenzylamine (PBA)

Same as for method B, above.

For multiple point calibration using BSTFA, prepare the different levels analogous to
method B, above, as follows: take 20, 40, 60, 80 and 100 애L of ATS standard stock solu-
tion, to each calibration level, add 100 애L of internal standard solution, and 50 애l of
BSTFA. Add chloroform to make up to 1ml.
Preparation of sample solutions (unknown ATS sample)

(a) Accurately weigh sample into a 25 ml volumetric flask to obtain a final concentra-
tion of approximately 0.2-1 mg/ml of analyte. Make to the mark with water. (Note:
Amount of the sample to be weighed will depend on anticipated purity as indicated
by the preliminary screening method. As an example, if the anticipated purity is about
40%, the sample amount used should be approx. 60 mg.)
5 ml of chloroform.
transfer approximately 1 ml of this sample solution through anhydrous sodium sul-
phate into a small beaker. Measure 100 애l of sample solution, 100 애l of internal
standard solution, 750 애l of chloroform and 50 애l of BSTFA into a GC sample vial.
(d) Inject into the gas chromatograph.
Column: HP-5, 0.32 mm x 30m x 0.5 애m
Carrier gas: Helium at approx. 1.2 ml/min (head pressure 12 psi)
Oven temperature: 100°C for 4 min., then 5°C/min to 200°C, then 10°C/min to
270°C, and hold for 1 minute
Detector (FID): 270°C
Approximate retention times
Pseudoephedrine-TMS 14.99 min.

Ephedrine-TMS 15.16 min.
Phenylbenzylamine-TMS (lS) 23.49 min.
Caffeine 26.22 min.
Ketamine-TMS 26.75 min.
2C-B-TMS 27.91 min.
Calculations
For routine analysis, the computer software will perform the calculations upon completion
of the analytical run. The result will be automatically printed on a report and expressed as
%w/w of an analyte as a base (i.e., weight of analyte, relative to sample weight).
Annex V. Validated HPLC method for
quantitation of selected ATS
Below is a validated method for the HPLC quantitation of selected ATS solutes including
amphetamine, methamphetamine, phentermine and MDMA.
HPLC Method for quantitation of ATS

ATS standard solution
Weigh an appropriate amount of standard ATS(s) into a volumetric flask to obtain a final
concentration of approximately 0.50 mg/ml. Dilute to volume with methanol.
ATS sample solution

Weigh an appropriate amount of sample into a volumetric flask so that the final phenethl-
amine concentration is approximately that of standard solution. Dilute to volume with
methanol.
HPLC operating conditions

Column: 5 애m Luna C18 (Phenomenex, Torrance, CA, USA) 150 x
3.0 mm
Column temperature: 35°C
Injection: 5 애l
Mobile phase: 10% acetonitrile, 90% (50 mM phosphate + 50 mM tri-
ethanolamine, pH 2.2);a flow rate 1.0 ml/min
UV wavelength: 210 nm
a
The buffer is prepared by dissolving 22.5 ml concentrated phosphoric acid into 4 liters of HPLC
grade water. Approximately 25 ml triethanolamine is added slowly to adjust solution to pH of
2.2.
Approximate relative migration times
Nicotinimide 0.28
Phenethylamine 0.55
Phenylpropanolamine 0.56
Doxylamine 0.56
Procaine 0.62
Ephedrine 0.64
Pseudoephedrine 0.65
Amphetamine 0.82
Acetominiphen 0.93
69
Approximate relative migration times (continued)
Methamphetamine 1.00 (2.7 min)

MDA 1.00
Quinine 1.04
Chloroquine 1.09
Dimethylamphetamine 1.12
MDMA 1.18
Caffeine 1.48
Lidocaine 1.50
MDEA 1.55
Ketamine 1.95
Chlorpheniramine 1.99
P2P 3.17
Safrole 3.50
Quaifenesin 3.61
Aspirin 5.09
Calculations
The percentage ATS content of the sample is calculated from the ATS peak area, and the
peak area and concentration of the relevant ATS standard.
Further reading
Malone, J.V. (1998). HPLC Quantification of Clandestinely Manufactured Mixtures of

Amphetamine and Methamphetamine, Microgram, vol. 31, pp. 304-307
Annex VI. Validated CE method for quantitation
of selected ATS
Below is a validated method for the CE quantitation of selected ATS solutes including
amphetamine, methamphetamine, MDA, MDMA and MDEA on an Agilent HP3D CE instru-
ment. Note that conditions such as capillary length, capillary temperature, voltage, flush
times and pressures and injection parameters could change with other instrument
manufacturers.
Dynamically coated capillary method for quantitation of ATS

Injection solvent
Weigh 1034 mg of sodium phosphate monobasic into 100 ml volumetric flask. Dilute to
volume with HPLC grade water (adjust pH to approximately 2.6 using phosphoric acid
and add dropwise). Transfer contents into a 2000 ml volumetric flask with aid of HPLC
grade water. Dilute to volume with HPLC grade water. This final solution contains 3.75 mM
phosphate, pH 3.2. Alternatively, transfer entire contents (with aid of HPLC grade water)
of 250 ml bottle of injection solvent concentrate (MicroSolv, Eatontown, NJ, USA) into 5
litre flask. Dilute to volume with HPLC grade water.
ATS internal standard solution

Weigh an appropriate amount of N-butylamphetamine HCl (or an appropriate internal
standard) into a volumetric flask to obtain a final concentration of approximately 1.0 mg/ml.
Dilute to volume with injection solvent.
ATS standard solution

Weigh an appropriate amount of standard ATS(s) into a volumetric flask to obtain a final
concentration of approximately 0.08 mg/ml. Pipette appropriate amount of internal stan-
dard solution to obtain a final concentration of 0.1 mg/ml. Dilute to volume with injection
solvent.
ATS sample solution

Weigh an appropriate amount of sample into a volumetric flask so that the final phenethyl-
amine concentration is approximately that of standard solution. Pipette appropriate amount
of internal standard solution to obtain a final concentration of 0.1 mg/ml. Dilute to
volume with injection solvent.
71
CE operating conditions (Achiral)

Capillary: Bare silica 32 cm (23.5 cm to detector window) by 50 애m i.d.
Capillary temperature: 15°C
Conditioning: 1 minute 0.1N sodium hydroxide; 1 minute water; 1 minute
CElixir A (MicroSolv); 2 minute CElixir B, pH 2.5
(MicroSolv).
Injection: 50 millibar x 2 second of sample followed by 35 millibar x
1 second of water
Run buffer: CElixir B, pH 2.5
Voltage: 10 kV
UV wavelength: 195 nm
Doxylamine 0.76
Chlorpheniramine 0.78
Quinine 0.80
Beta-phenethylamine 0.81
Chloroquine 0.81
Nicotinimide 0.84
Amphetamine 0.87
Methamphetamine 0.88
Procaine 0.88
MDA 0.90
Norpseudoephedrine 0.91
MDMA 0.91
Norephedrine 0.92
Pseudoephedrine 0.92
Tetracaine 0.93
Ephedrine 0.93
Phenylephrine 0.95
MDEA 0.96
Ketamine 0.96
Phenyltoxylamine 0.97
N-Butylamphetamine (IS) 1.00 (4.6 min)
Methorphan 1.00
Lidocaine 1.03
Benzocaine 1.25
Acetominophen 2.11
Caffeine 2.14
Quaifenesin 2.14
P2P 2.24
DMSO (neutral marker) 2.40
Aspirin 2.71
Calculations
The content (%) of the unknown ATS is calculated from its peak area, and the peak area
and concentration of the ATS standard, relative to the peak area of the internal standard
(standard and sample).
Annex VI. Validated CE method for quantitation of selected ATS 73
CE operating conditions (Chiral)

Capillary: Bare silica 32 cm (23.5 cm to detector window) by 50 애m i.d.
Capillary temperature: 15°C
Conditioning: 1 minute 0.1N sodium hydroxide; 1 minute water; 1 minute
CElixir A (MicroSolv); 2 minute CElixir B, pH 2.5 + 50 mM
2-Hydroxypropyl-웁-Cyclodextrin (MicroSolv).
Injection: 50 millibar x 2 second of sample followed by 35 millibar x
1 second of water
Voltage: 20kV
UV wavelength: 195 nm (bandwith 10 nm)
l-Norpseudoephedrine 0.81
d-Norephedrine 0.83
l-Norephedrine 0.83
l-Pseudoephedrine 0.83
l-Amphetamine 0.85
d-Ephedrine 0.86
d-Amphetamine 0.86
l-Ephedrine 0.87
l-Methamphetamine 0.87
d-Norpseudoepherine 0.88
d-Methamphetamine 0.89
d-Pseudoephedrine 0.90
N-Butylamphetaminea 1.00 (3.75 min)
N-Butylamphetaminea 1.02
MDAa 1.03
MDAa 1.04
MDMAa 1.05
MDMAa 1.07
MDEAa 1.10
MDEAa 1.12
a
d or l-enantiomer
Further reading
Lurie, I. S., Hays, P. A. and Parker, K. P. (2004). Capillary Electrophoresis Analysis of a

Lurie, I. S., Bethea, M. J., McKibben, T. D., Hays, P. A., Pellegrini, P., Sahai, R., Garcia,
A. G. and Weinberger R. (2001). Use of Dynamically Coated Capillaries for the Routine
Analysis of Methamphetamine, Amphetamine, MDA, MDMA, MDEA and Cocaine using
Capillary Electrophoresis, J. Forensic Sci., vol. 46, pp. 1025-1032.
Annex VII. Derivatizations
Derivatization of ATS is not mandatory, since the majority of ATS is amenable for GC
analysis and thermally stable. However, derivatization of ATS (primary or secondary
amines) improves their chromatographic properties by reducing undesirable and non-
specific column adsorption as well as matrix interferences.
The derivatization methods recommended below work successfully for most of the
commonly encountered ATS, however, in rare occasions, the reaction conditions such as
reaction time or temperature have to be adjusted.
Analytical note
If derivatization is chosen as a method of sample preparation, sample extraction
should be performed as described in the relevant sections above. Following the
extraction, the solvent should be evaporated to dryness under a gentle stream of
nitrogen at room temperature, or alternatively at 30ºC. In order to avoid loss of ana-
lyte by evaporation, this step should be performed very carefully, especially for quan-
titative ATS analysis. The most efficient way of preventing evaporation of analytes
is to evaporate the solvent to approximately 1 ml and then add a few drops (50 애l)
of a solvent with high boiling point (solvent keeper), for example, dimethylfor-
mamide. After addition of the solvent keeper, further evaporation should proceed
carefully until only a thin film of solvent remains. The sample is now ready for
derivatization using one of the recommended methods.
Derivatization procedures
Acetylations
Heptafluorobutyric anhydride (HFBA)

Procedure A (acetylation with anhydride)
Add 50 애l of HFBA to the dry residue of extracted ATS in a reacti-vial.* Cap vial, shake
for 30 seconds and incubate for 20 min at 75ºC. Evaporate excess reagent. Reconstitute
the dry residue in 50 애l of ethyl acetate, and inject 1-2 애l into the GC column.
Procedure B (acetylation with anhydride in presence of a basic catalyst)

Add 50 애l of 0.5M potassium hydroxide to the dry residue of extracted ATS followed by
500 애l of toluene. After mixing and centrifugation, transfer the organic layer into a clean
*Reacti-vials are screw-cap vials made of thick, temperature resistant glass, usually with a coni-
cally shaped bottom part inside the vial. In the absence of specialized vials, derivatization can be done
in any Teflon-lined screw-cap test tube.
75
test tube, and add 50 애l of HFBA. Mix thoroughly and immediately add 500 애l of 10%
w/v sodium bicarbonate with continuous mixing. Centrifuge the test tube until the upper
toluene layer is separated. Inject 1-2 애l of toluene layer into the GC column.
Pentafluoroacetic anhydride (PFAA)

Add 50 애L of PFAA to the dry residue of extracted ATS in a reacti-vial. Cap vial, shake
for 30 seconds and incubate for 20 min at 75ºC. Evaporate excess reagent. Reconstitute
the dry residue in 50 애l of ethyl acetate, and inject 1-2 애L into the GC column
Trifluoroacetic anhydride (TFAA)

Add 100 애L of ethyl acetate and 50 애L of TFAA to the dry residue of extracted ATS in
a reacti-vial. Cap vial, shake for 30 seconds and incubate for 20 min at 60ºC. Evaporate
excess reagent. Reconstitute the dry residue in 50 애L of ethyl acetate, and inject 1-2 애l
into the GC column.
N-Methylbis-trifluoroacetamide (MBTFA)
Add 500 애L MBTFA to the dry residue of extracted ATS in a reacti-vial. Cap vial, shake
for 30 seconds and incubate for 30 min at room temperature. Evaporate excess reagent.
Reconstitute the dry residue in 50 애L of ethyl acetate, and inject 1-2 애l into the GC
column.
Since MBTFA elutes early in the GC analysis, evaporation of excess reagent may not be
necessary if the analyte concentration is anticipated to be large enough for direct injection
of the derivatizaion mixture.
Further reading
M. Doneke, J. Chromatography, vol. 78, p. 273, (1973)
Silylation
N-Methyl-N-tert.-butyl-dimethylsilyl trifluoroacetamide (MTBSTFA)

Add 100 애l of acetonitrile and 150 애L of MTBSTFA to the dry residue of extracted ATS.
Cap the vial and heat for 15 min at 90ºC. Leave the sample at ambient temperature for
another 2 h, or more, especially if hindered secondary amino groups are to be silylized.
Add 500 애L of acetonitrile, mix well, and inject 1-2 애L into the GC column (if low ana-
lyte concentrations are anticipated, the sample may be injected directly without dilution
with acetonitrile).
Alternatively, to avoid MTBSTFA peak early in the GC chromatogram, combine the dry
residue of extracted ATS with 100 애L of acetonitrile and 100 애L MTBSTFA in a 3 ml
vial. Seal vial and allow mixture to stand for 2 h. Add 100 애L of water to hydrolyse any
unreacted MTBSTFA. Add 250 애L of n-hexane, mix vigorously and centrifuge. Decant
upper hexane layer and inject 1-2 애l into the GC column.
Annex VII. Derivatizations 77
Further reading
R. Melgar, R. C. Kelly, J. Anal. Toxicol., vol. 17 (Nov./Dec., 1993), p. 399.
N,O-bis-[(trimethylsilyl)trifluoroacetamide] (BSTFA)
Add 50 애L of BSTFA and 100 애L of acetonitrile to the dry residue of extracted ATS in
a reacti-vial. Cap vial, shake and incubate for 15 min at 70° C. Inject 1-2 애L into the GC
column.
Chiral derivatization
ATS diastereoisomer substrates can be prepared using many different reagents such as
acylchlorides, alkylsulphonates, isothiocyanates, chloroformates, but the two listed below
are the most popular.
R(+)/S(-)-움-methoxy-움-(trifluoromethyl)-phenylacetic acid (Mosher’s acid), or

R(+)/S(-)-움-methoxy-움-(trifluoromethyl)-phenylacetic acid chloride (Mosher’s acid chloride)
Dissolve the dry sample residue of extracted ATS in 1 ml of THF and mix with 0.5 ml
of 0.2 M solution of Mosher’s acid in THF in a reacti-vial with a Teflon-lined screw cap.
Add 0.5 ml of 10% w/v solution of sodium bicarbonate, cap the vial and heat at 65°C
for 1 h. Extract the aqueous phase with chloroform, dry with magnesium sulphate, and
evaporate to dryness. Reconstitute the residue in a suitable solvent for GC analysis
(e.g., chloroform, see section on qualitative GC analysis, above).
Instead of Mosher’s acid, the corresponding chloride can be used. It is commercially avail-
able, or can be prepared by refluxing the acid with thionyl chloride. Acid chlorides are
usually more reactive, although Mosher’s acid itself results in quantitative derivatization
of most amines, with the exception of ephedrine and pseudoephedrine. Mosher’s acid or
its derivatives can be used as reagents for both GC and HPLC analysis.
N-trifluoroacetyl-L-prolyl chloride (TPC, or TFAP-Cl)

Dissolve the dry sample residue of extracted ATS in 2 ml of dry chloroform. Add 4 ml
of TPC reagent. Stir or shake the mixture, and then add 40 mg of dry triethylamine.
Continue to stir for 15 minutes. Wash with 3 ml of 6 N HCl and then with water. Add
MgSO4 and allow the mixture to stand for 15 minutes. Inject 1-2 애L into the GC column.
TPC is known to produce stable derivatives of almost all ATS including ephedrines. It is
more amenable for GC analysis.
*0586466*
Printed in Austria
V.05-86466—Janaury 2006—600
United Nations publication
Sales No. E.06.XI.1
ISBN 92-1-148208-9
ST/NAR/34
Vienna International Centre, P.O. Box 500, 1400 Vienna, Austria
Tel: (+43-1) 26060-0, Fax: (+43-1) 26060-5866, www.unodc.org
RECOMMENDED METHODS FOR

THE IDENTIFICATION AND ANALYSIS OF
ANALOGUES IN SEIZED MATERIALS

Amphetamine, Methamphetamine and Their Ring-Substituted Analogues in Seized Materials

Uploaded by

Copyright:

Available Formats

Amphetamine, Methamphetamine and Their Ring-Substituted Analogues in Seized Materials

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Amphetamine, Methamphetamine and Their Ring-Substituted Analogues in Seized Materials

Uploaded by

Copyright:

Available Formats

Vienna International Centre, P.O.

Box 500, 1400 Vienna, Austria

RECOMMENDED METHODS FOR

MANUAL FOR USE BY NATIONAL DRUG TESTING LABORATORIES

RECOMMENDED METHODS FOR THE

MANUAL FOR USE BY NATIONAL DRUG TESTING LABORATORIES

UNITED NATIONS PUBLICATION

Ms. Rosa Alis Rodríguez, Laboratorio de Drogas y Sanidad de Baleares,

Dr. Hans Bergkvist, SKL—National Laboratory of Forensic Science,

Ms. Warank Boonchuay, Division of Narcotics Analysis, Department of

Dr. Rainer Dahlenburg, Bundeskriminalamt/KT34, Wiesbaden, Germany

Mr. Adrian V. Kemmenoe, The Forensic Science Service, Birmingham

Dr. Waldemar Krawczyk, Central Forensic Laboratory of the Police, Ministry

Dr. Yukiko Makino, Narcotics Control Department, Kanto-Shin’etsu Bureau

Mr. Tim McKibben, Special Testing and Research Laboratory, Drug

Ms. Anneke Poortman, Forensic Science Laboratory, Ministry of Justice,

Ms. Jana Skopec*, Australian Government Analytical Laboratories, Pymble,

*Now with Agrifor Scientific Pty Ltd., Australia.

II. Use of the manual . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

IV. Description of pure compounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

International attention is focusing more and more on the growing issue of

All manuals, as well as guidelines and other scientific-technical publications may

Amphetamine-type stimulants (ATS) are a group of substances, mostly synthetic

Seized ATS are commonly encountered in the form of salts, in particular as

in a typical stereochemical make-up. Amphetamine, for example, and most ring-

Knowledge of illicit manufacturing routes of drugs of abuse can play an impor-

Leuckart reaction (non-metal reduction)

Figure III. Leuckart reaction used in illicit amphetamine manufacture

Reductive amination (catalytic metal reduction)

Reductive amination is a process of catalytic or chemical reduction of aldehydes

(a) Heterogeneous catalytic reduction using platinum oxide, palladium or

Heterogeneous catalytic reduction is usually achieved by using a mixture of

Other, less frequently used reductive amination methods include metal

Methamphetamine can be also synthesized using the above methods by replacing

(a) non-metal reductions such as the “hydriodic acid-red phosphorus”

Figure IV. Common routes for illicit methamphetamine manufacture

Dissolving metal reduction (Birch reduction)

Figure IV. (continued)

Heterogeneous catalytic reduction (Emde route)

ephedrine or chloroephedrine methamphetamine

Other reactions, such as the “nitropropene” or “oxime” route, are rarely

Birch reduction: this proceeds via a dissolving metal reduction of ephedrine

C. SYNTHESIS OF RING-SUBSTITUTED ATS

The most commonly encountered methylenedioxy-type ATS is MDMA, and

Figure V. Reductive amination used in illicit MDMA manufacture

3,4-MDP-2-P methylamine imine

Analogous to illicit amphetamine manufacture, a method commonly used in

2C-B is manufactured by reacting 2,5-dimethoxybenzaldehyde and nitro-

Generally, in attempting to establish the identity of a controlled drug in sus-

Colour test techniques

Preparation of reagents is described in annex II. Reagents should be prepared

쐌 Add one drop of Simon Reagent 1 and stir.

Gallic acid test

Table 1. Colour test results

Compound Marquis reagent Simon reagent Chen reagent

Amphetamine Orange, slowly NR* NR*

Compound Marquis reagent Simon reagent Chen reagent

DMA green --> dark green NR*

(a) ATS specific